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 The nonsense-mediated mRNA decay (NMD) pathway functions as a quality 
control mechanism and a feature of post-transcriptional gene regulation. NMD degrades 
mRNAs containing premature termination codons (PTCs) to prevent the production of 
potentially harmful truncated proteins, and it also destroys many error-free endogenous 
mRNAs to limit the expression of these genes. NMD is critical for viability in most 
complex organisms, highlighting the importance of this pathway; however, it is unknown 
which of the two NMD functions is the feature essential for viability. Understanding how 
NMD recognizes and degrades targets may provide insight to uncover the requirement of 
this pathway for viability, but the molecular mechanisms of NMD target recognition and 
destruction also remain unclear. Work presented in this dissertation describes genetic 
analysis in Drosophila to reveal the feature of the NMD pathway that is critical for 
viability, and refines the model describing the mechanism of NMD target degradation. 
We screened a collection of heterozygous deficiencies for suppression of the incomplete 
lethality of a hypomorphic allele of the core NMD factor Upf2. This screen identified 
three autosomal regions that partially suppress Upf2 mutant lethality when deleted. The 
endogenous NMD target Gadd45 is located within one suppressing region, and we found 
that elimination of Gadd45 restores viability to multiple null NMD mutants. Mekk1, a 
factor that acts downstream of Gadd45, resides in another suppressing region, and loss of 
Mekk1 also restores viability to NMD mutants. The third suppressing region contains 
!! iv!
Arc2, and we found that Arc2 and the closely related Arc1 may also contribute to the 
lethality of Drosophila lacking NMD activity. In addition, this dissertation describes the 
first genetic analysis of Drosophila Smg5 mutants, and determines that Smg5 is a critical 
NMD factor required for viability and all NMD function. Further analysis of the first 
characterization of double mutants for multiple NMD factors reveals there are multiple 
mechanisms for NMD target degradation. These findings provide a new foundation for 
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 The precise temporal and spatial control of gene expression in response to 
genetic and environmental cues is a fundamental aspect of development. Indeed, the mis-
expression of genes is the driving force behind many diseases. Factors that impact 
mRNA transcription are usually focused on as the key aspect of gene expression, 
however post-transcriptional regulation of mRNA stability also has a major influence. 
The importance of post-transcriptional gene regulation is highlighted by the diseases that 
can occur when many of the factors that regulate this process are disrupted (Cooper et 
al., 2009). Thus, understanding mRNA degradation is critical to comprehending the 
regulation of gene expression and the detrimental effects caused by loss of this activity. 
 There are a variety of mRNA decay mechanisms, which can broadly be classified 
as general or specific. General mRNA decay occurs after deadenylation or removal of 
the 5’ m7G-cap. These events allow for 5’-to-3’ and 3’-to-5’ exonucleases, respectively 
XRN1 and the Exosome complex, to have access to the mRNA (Chen and Shyu, 2011). 
Specific decay mechanisms require the presence of cis-acting features for mRNA to be 
recognized by such pathways. These specific decay pathways have two main features: 
regulatory mechanisms that maintain proper levels of gene expression, and surveillance 
mechanisms that ensure mRNA quality (Adjibade and Mazroui, 2014). The regulatory 
mechanisms include pathways that use proteins to recognize sequence- or structure-
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specific features of targets, such as ARE-mediated, GU-mediated, CDE-mediated, and 
IRE1-dependent decay, and pathways that require non-coding RNAs to recognize 
targets, such as miRNA-mediated decay (Adjibade and Mazroui, 2014; Maurel et al., 
2014). Surveillance mechanisms do not require recognition of any specific sequence or 
structure, but instead recognize errors occurring during translation and destroy the 
defective mRNAs. These surveillance pathways include nonstop decay, which destroys 
mRNAs with no stop codon when the ribosome reaches the poly-A tail (Vasudevan et 
al., 2002), and no-go decay, which initiates the destruction of mRNAs with stalled 
translation elongation complexes (Harigaya and Parker, 2010).  
One mRNA decay pathway, nonsense-mediated mRNA decay (NMD), straddles 
the classification of regulatory or surveillance mechanism (Celik et al., 2015; Peccarelli 
and Kebaara, 2014). The NMD pathway was first identified as a mechanism that 
degrades mRNAs containing premature termination codons (PTCs) (Celik et al., 2015). 
A PTC is an erroneous stop codon that occurs in the open reading frame prior to the 
endogenous stop, usually caused by a nonsense mutation or error in mRNA splicing or 
transcription (Kurosaki and Maquat, 2016). By degrading PTC-containing mRNAs, 
NMD prevents the translation of truncated polypeptides that can have dominant 
detrimental effects in the cell (Miller and Pearce, 2014). NMD was later discovered to 
also degrade many wild-type mRNAs as a mechanism of post-transcriptional gene 
regulation, possibly because these mRNAs contain features that simulate PTCs 
(Peccarelli and Kebaara, 2014). Both the quality control and gene-regulatory activities of 
NMD are conserved in all eukaryotes (Conti and Izaurralde, 2005), indicating that these 
functions are critical features of the NMD pathway. These dual roles of NMD suggest it 
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is a crucial aspect of cellular mRNA metabolism. The modulation of NMD activity is a 
potential therapy for a wide range of genetic diseases (Keeling and Bedwell, 2011). 
Some alleles produce PTC-containing mRNAs that manage to evade NMD and can 
cause dominantly-inherited disease. In these cases, increasing NMD activity may serve 
to alleviate the severity of such diseases (Bhuvanagiri et al., 2010). Additionally, many 
recessive genetic diseases are caused by loss of protein function due to the PTC-
containing mRNAs being degraded by NMD. In these cases, suppression of NMD 
activity may allow for translation of partially functional proteins and restore some gene 
activity, reducing disease symptom severity (Keeling and Bedwell, 2011). When 
considering potentially altering NMD activity, it is particularly important to understand 
the mechanisms of target recognition and degradation to identify how to manipulate 
these functions. In addition, it is important to understand the biological processes 
regulated by the NMD pathway to recognize possible side-effects that may result from 
enhancing or inhibiting NMD activity. This dissertation will describe work to understand 
the mechanisms of NMD targeting and decay, as well as the requirement for the gene 
regulatory NMD function. 
 
Components of the NMD Complex 
 The phenomenon of the instability of PTC-containing mRNAs has been well 
known since the 1970s (Losson and Lacroute, 1979). However, it was not until the late 
1980s and early 1990s that the first molecular factors required for NMD were identified 
through forward genetic screens in yeast and C. elegans (Hodgkin et al., 1989; Leeds et 
al., 1991; 1992). Many separate groups identified mutants that suppressed defects caused 
by PTC-containing alleles of diverse genes. The suppressor mutations identified in S. 
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cerevisiae were mapped to three genes and named up frameshift (upf) 1-3, because they 
suppressed a +1 frameshift mutation of his4 that created a PTC (Leeds et al., 1991; 
1992). The C. elegans alleles mapped to six loci and were termed suppressor with 
morphological effect on genitalia (smg) 1-6 because they suppressed the paralysis defect 
of unc-54 and other mutants, and showed morphological defects of both male and female 
genitals (Hodgkin et al., 1989). A seventh C. elegans NMD factor, smg-7, was later 
identified through similar analysis (Cali et al., 1999). upf1, upf2, and upf3 are 
orthologues of smg-2, smg-3, and smg-4, respectively (Aronoff et al., 2001; Johns et al., 
2007; Page et al., 1999), and all seven worm factors are highly conserved throughout 
metazoans. 
 While these screens were the first to identify the NMD factors, they were not a 
comprehensive identification of all of the components contributing to NMD activity. 
One major limitation to these screens was that they could only identify viable mutants. 
Future screens in C. elegans using an RNAi approach identified two other genes, called 
smg lethal-1 (smgl-1) and smgl-2, which are required for both NMD and viability in 
these animals (Longman et al., 2007). Two additional factors, called smg-8 and smg-9, 
were later identified to bind smg-1 in HeLa cells, and homologues of these genes are 
found in C. elegans (Yamashita et al., 2009), however their contribution to NMD 
function remains unclear (Rosains and Mango, 2012). Although potential NMD factors 
continue to be identified (Cho et al., 2013; Melero et al., 2016), Upf1, Upf2, Upf3, Smg1, 
Smg5, Smg6, and Smg7 are generally focused on as the major factors contributing to 
NMD activity due to their high conservation and the strong NMD defects that occur in 
any eukaryote when their function is lost. 
!!
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 A series of studies characterizing the molecular interactions between NMD 
factors, combined with mutant analysis in yeast and C. elegans, have provided a working 
model of the protein interactions that occur during NMD after target recognition (Figure 
1.1). Characterization of Upf1 protein function found it has RNA-dependent ATPase and 
RNA helicase activities, in addition to an ability to bind mRNA, all of which are 
required for NMD targets to be degraded (Czaplinski et al., 1995; Weng et al., 1996b; 
1996a). The ATPase activity stimulates Upf1 to dissociate from mRNAs, and Upf1 that 
cannot bind or hydrolyze ATP promiscuously binds both target and non-target mRNAs 
(Franks et al., 2010; Lee et al., 2015), suggesting that Upf1 may bind all mRNAs 
transiently. The inhibition of Upf1 ATPase activity when bound to PTC-containing 
mRNAs is then likely a critical feature of NMD target recognition. The specificity of 
Upf1 binding to PTC-containing mRNAs may be due to the interaction between Upf1 
and the translation termination factor eRF3 at PTCs, which blocks Upf1 ATPase activity 
(Czaplinski et al., 1998). During normal translation termination, Poly-A Binding Protein 
1 (PABP1) binds eRF3, promoting a stable, continuously translated messenger 
ribonucleoprotein (Cosson et al., 2002; Hoshino et al., 1999), and this interaction 
antagonizes Upf1 binding to eRF3 (Singh et al., 2008). The probability of Upf1 binding 
eRF3 is likely determined by the proximity of PABP1 to eRF3 during translation 
termination, since tethering PABP1 near a PTC is sufficient to block Upf1 binding (Lee 
et al., 2015). Thus, it is likely that the increased distance between the site of translation 
termination and the poly-A tail caused by a PTC allows for Upf1 to bind eRF3, 




Upf1 protein was found to stably interact in a complex with Upf2 and Upf3, via 
directly binding Upf2, which bridges the interaction between Upf1 and Upf3 (He et al., 
1997; Lykke-Andersen et al., 2000). This interaction with Upf2 stimulates Upf1 ATPase 
and helicase function (Chakrabarti et al., 2011; Chamieh et al., 2007) and is required for 
the degradation of NMD targets (He et al., 1996), indicating the assembly of this 
complex on a target mRNA is a critical step in the NMD pathway. Upf3 promiscuously 
binds mRNAs through direct interaction with the exon-exon junction complex (EJC) 
(Gehring et al., 2003), and Upf2 also associates with EJC factors, likely thorough its 
binding with Upf3 (Le Hir et al., 2001). Tethering of EJC factors or any one of the Upf 
proteins to an mRNA downstream of a stop codon is sufficient to induce degradation 
(Lykke-Andersen et al., 2000; 2001), suggesting that an EJC downstream of a PTC can 
promote NMD activity. These findings support a model where Upf1 interacts with eRF3 
at PTCs, blocking ATPase activity and maintaining binding to the mRNA, which cannot 
be released until Upf2 binds Upf1. When an EJC is located downstream of this PTC, 
Upf3 bound to the EJC increases the likelihood for Upf2 to interact with Upf1, forming a 
stable complex of these three proteins bound to the mRNA through Upf1 and the EJC 
(Figure 1.1B). Upf2 then activates the Upf1 ATPase and helicase, initiating NMD 
activity.   
The characterization of the binding activities of the Upf proteins can explain how 
the NMD complex is recruited to PTC-containing mRNAs, but it does not solve the 
mechanisms of mRNA degradation. Upf1 has been shown to interact with members of 
the Dcp decapping complex in both yeast and human cells (Lykke-Andersen, 2002; 
Tarassov et al., 2008), suggesting it may promote decapping and subsequent 5’-to-3’ 
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exonucleolytic degradation of target mRNAs. In fact, the 5’-to-3’ exonuclease xrn1 is 
required for degradation of NMD target mRNAs in yeast (He and Jacobson, 2001), 
suggesting decapping is the major mechanisms for target degradation in yeast. NMD also 
initiates decapping of target mRNAs in human cells (Lejeune et al., 2003); however, 5’-
to-3’ exonuclease only appears to be a minor factor in the degradation of human NMD 
targets (Lykke-Andersen et al., 2014), indicating most NMD activity occurs through a 
different mechanism in human cells. It is likely that this difference in the degradation 
mechanism between yeast and human cells is due to the additional NMD factors that are 
present in metazoans. 
The first clue as to the function of the metazoan-specific NMD genes was 
revealed when SMG-2 (Upf1) was discovered to be phosphorylated in C. elegans (Page 
et al., 1999). The phosphorylation of SMG-2 was dependent on smg-1, smg-3 (Upf2), 
and smg-4 (Upf3), and SMG-2 was hyper-phosphorylated in smg-5, smg-6, and smg-7 
mutants (Page et al., 1999). Smg1 was then discovered to be a phosphatidylinositol 
kinase (PIK)-related kinase that is required for phosphorylation of Upf1 in both human 
cells and C. elegans (Grimson et al., 2004; Yamashita et al., 2001). Upf1 is 
phosphorylated at multiple residues in the N-terminal and C-terminal regions (Okada-
Katsuhata et al., 2012); however, it is unclear if Smg1 contributes to the phosphorylation 
of all of these residues, and if all phosphorylation occurs after target recognition or if 
some occurs prior to complex assembly. However, since smg-3 and smg-4 are also 
required for SMG-2 phosphorylation in C. elegans (Page et al., 1999), it is likely that 
SMG-1 cannot phosphorylate SMG-2 until after complex assembly. Interestingly, the 
Upf1 orthologue in S. cerevisiae, which do not express a Smg1 orthologue, is 
!!
8!
phosphorylated at 11 residues, some of which are potentially phosphorylated in other 
organisms (Lasalde et al., 2014), suggesting Smg1-independent Upf1 phosphorylation 
also occurs. Importantly, loss of Smg1 causes defects in NMD activity in human cells 
and C. elegans (Hodgkin et al., 1989; Yamashita et al., 2001), indicating that the 
phosphorylation of Upf1 by Smg1 is a key step in the NMD mechanism (Figure 1.1C). 
 The phosphorylation of Upf1 alone does not explain how an NMD target is 
degraded, so some other mechanisms is likely activated by this modification. The 
mechanism of degradation first began to become clear when it was identified that NMD 
targets in Drosophila cells are cleaved by an endonuclease near the PTC site, producing 
two fragments: one with a 5’ cap and an exposed 3’ end, and a second with an exposed 
5’ end and a poly-A tail (Gatfield and Izaurralde, 2004). The exposed ends of these 
fragments would then be accessible by general exonucleases to be destroyed (Gatfield 
and Izaurralde, 2004). Analysis of the Drosophila Smg6 protein sequence uncovered a 
Pilt N-terminus (PIN) domain, a domain that is capable of having endonuclease activity 
(Glavan et al., 2006). The Smg6 PIN domain was later shown to be both necessary and 
sufficient for endonucleolytic cleavage of NMD targets in Drosophila and human cells 
(Huntzinger et al., 2008), revealing Smg6 as the endonuclease that cleaves NMD targets. 
Smg6 sequence analysis also discovered a 14-3-3-like domain, which is capable of 
binding phosphorylated proteins (Fukuhara et al., 2005), and Smg6 was found to bind 
phosphorylated Upf1 (Okada-Katsuhata et al., 2012), suggesting Upf1 phosphorylation 
by Smg1 is required for recruitment of Smg6 endonuclease. Smg6 has been shown to be 
capable of binding Upf1 in the absence of Smg1 kinase function, and is required for 
NMD even when Smg1 is depleted (Chakrabarti et al., 2014; Nicholson et al., 2014), 
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suggesting that Smg1 may not be needed to recruit Smg6. However, it has remained 
unclear if Smg1-independnent Smg6 activity occurs during native NMD conditions, or if 
Smg1 serves to enhance Smg6 binding to Upf1, even if Smg6 can bind on its own. These 
findings all support the model that Smg6 is recruited to phosphorylated Upf1, likely after 
Smg1 kinase activity, (Figure 1.1D), and then cleaves target mRNAs near the stop 
codon, exposing free 5’ and 3’ ends, which are then degraded by exonucleases without 
the removal of the 5’ cap or deadenylation (Figure 1.1E). 
Smg5 and Smg7 both have 14-3-3-like domains, and form a heterodimer to also 
bind phosphorylated Upf1, which is required for NMD activity (Anders et al., 2003; 
Fukuhara et al., 2005; Jonas et al., 2013; Ohnishi et al., 2003) (Figure 1.1D). The 
contribution  of Smg5 and Smg7 to NMD is the least clear, but there is evidence to 
suggest a few different possibilities. The Smg5/Smg7 complex binds a subunit of the 
PP2A phosphatase (Anders et al., 2003; Ohnishi et al., 2003), and C. elegans and human 
cells lacking Smg5 or Smg7 have hyper-phosphorylated Upf1 (Ohnishi et al., 2003; Page 
et al., 1999), suggesting Smg5 and Smg7 are required for Upf1 to be dephosphorylated 
after target degradation is initiated. Interestingly, Smg6 is also required for 
dephosphorylation of Upf1 (Chiu et al., 2003; Page et al., 1999), suggesting 
endonuclease activity may be required before Upf1 can be dephosphorylated, or Smg6 
binding Upf1 is necessary for the Smg5/Smg7 dimer to also bind. It is unclear how this 
potential role in Upf1-dephosphorylation contributes to NMD activity, but it has been 
suggested to be required for NMD complex disassembly and recycling (Ohnishi et al., 
2003) (Figure 1.1E), although this model has not been further substantiated. There is 
evidence suggesting Smg5 is also capable of recruiting the Dcp decapping complex via 
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an interaction with PRNC2 to potentially allow for 5’-to-3’ transcript degradation (Cho 
et al., 2013; 2009). Additionally, Smg7 has been shown to recruit a deadenylase complex 
through interaction with POP2 (Loh et al., 2013) to potentially allow for 3’-to-5’ 
degradation. However, the frequency of these interactions and if they contribute to NMD 
in native conditions remains unclear. Thus, Smg5 and Smg7 potentially have multiple 
roles in NMD, but their requirement for Upf1 dephosphorylation is the most well 
described, and thus generally referred to as their function. However, the necessity and 
relative contribution of each of the potential functions of these genes to NMD activity in 
vivo remains very unclear. 
 Piecing all of these steps together creates a canonical model of NMD pathway 
function. This model suggests the majority of NMD activity occurs through a single 
linear pathway, initiated by a complex of Upf1-3, then recruiting Smg1, which allows for 
Smg6 and Smg5/7 to be recruited, initiating decay and promoting complex recycling 
(Figure 1.1). Additional alternative decay mechanisms may potentially exist, such as 
Smg1-independent Smg6 activity, or decapping and deadenylation complex recruitment 
via Smg5 or Smg7, but the evidence for these activities to occur during natural NMD 
conditions remains limited. Genetic analysis of model organisms with mutations in 
individual NMD factors may be able to distinguish between the possible single or 
multiple decay mechanisms contributing to NMD. If NMD proceeds through a single 
pathway, loss of any individual NMD factor would cause the entire pathway to fail, 
producing similar defects when different individual NMD factors are inhibited. 
Alternatively, if multiple NMD mechanisms exist, then loss of any individual NMD 
factor will have differing effects on NMD activity. Interestingly, siRNA knockdown of 
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any of the known NMD factors in Drosophila S2 cells produces a similar profile of 
genome wide changes (Rehwinkel, 2005), suggesting all of these genes are equivalently 
required for NMD function. Additionally, mutations in any NMD gene generally have 
the same effect on viability within a given model organism. For example, all NMD loss-
of-function conditions tested in mouse, zebrafish, and Arabidopsis cause lethality 
(Kerényi et al., 2008; McIlwain et al., 2010; Medghalchi et al., 2001; Weischenfeldt et 
al., 2008; Wittkopp et al., 2009), while no NMD factors are essential for viability in C. 
elegans, S. cerevisiae, or S. pombe (Hodgkin et al., 1989; Leeds et al., 1991; Mendell et 
al., 2000). These genetic studies so far are consistent with the idea that all NMD factors 
are required for all NMD function. 
 An exception to this trend is Drosophila, in which different NMD factors have 
varied requirements for viability. Loss of Upf1 or Upf2 activity causes lethality in 
Drosophila, but animals are capable of living without Upf3, Smg1, or Smg6 (Avery et al., 
2011; Chen et al., 2005; Frizzell et al., 2012; Metzstein and Krasnow, 2006). Upf1 and 
Upf2 are known to function in NMD-independent processes, such as staufen-mediated 
decay and possibly in translation initiation (Park and Maquat, 2013; Wilkinson, 2005). It 
is possible that Drosophila are capable of living without any NMD activity and that Upf1 
and Upf2 mutants are dying due to loss of the NMD-independent functions of these 
genes. However, there is a correlation between the viability of an NMD allele and the 
expression of endogenous NMD targets with these alleles (Avery et al., 2011; Frizzell et 
al., 2012; Metzstein and Krasnow, 2006), indicating that the lethal alleles have more 
severe defects in NMD function than the viable alleles. Since there are differences in the 
severity of the NMD defects between Drosophila mutants lacking different NMD genes, 
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it suggests that the contribution to NMD function may not be equal between all NMD 
factors, as predicted by the canonical model of NMD activity. It is possible that those 
organisms which require all NMD genes for viability are very sensitive to any loss in 
NMD function, while those organisms that do not require NMD are not sensitive to any 
perturbation in NMD activity. Drosophila may reside at a pivotal point in the tree of life 
where some NMD activity is permissive for viability, but complete loss of NMD 
function causes lethality. For this reason, genetic analysis of Drosophila NMD mutants 
may be a powerful tool to understand the individual contribution of each factor to the 
NMD pathway. 
 Analysis of Drosophila Smg6 mutants is an example of the novel understandings 
of the NMD pathway that can be gained through investigating Drosophila NMD mutants 
(Frizzell et al., 2012). The canonical model of NMD activity proposes that Smg1 is 
required for any Smg6 to bind Upf1, and thus NMD activity (Figure 1.1C, D). 
Drosophila Smg6 mutants are semi-viable, with approximately 50% of mutants surviving 
to adulthood, while 100% of Smg1 mutants survive (Chen et al., 2005; Frizzell et al., 
2012; Metzstein and Krasnow, 2006), and Smg6 mutants have much higher expression of 
endogenous NMD targets than Smg1 mutants (Frizzell et al., 2012), indicating that Smg6 
mutants have a stronger defect in NMD activity than Smg1 mutants. This finding is 
consistent with the alternative model that Smg6 can bind Upf1 independent of Smg1 
phosphorylation (Chakrabarti et al., 2014; Nicholson et al., 2014), suggesting that Smg1-
independent binding occurs in vivo during native NMD activity. By continuing to use the 
benefits of dissecting the function of individual NMD factors through Drosophila 
genetics, Chapter 3 of this dissertation will describe how analysis of Smg5 mutants and 
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double mutants of NMD genes revealed novel features of the NMD pathway. 
 
Endogenous NMD Targets: How Are They Recognized? 
 The NMD pathway was first identified as a mechanism to remove PTC-
containing mRNAs from the cell. However, this quality-control feature is not the only 
NMD function. NMD also functions as a mechanisms of post-transcriptional gene 
regulation, degrading many wild-type mRNAs to reduce their expression. The regulation 
of these endogenous NMD targets is an important aspect of the overall landscape of gene 
expression, since loss of NMD activity in yeast, C. elegans, Drosophila, or mammalian 
cells can lead to changes in expression of approximately 10% of the genome (Barberan-
Soler et al., 2009; Chapin et al., 2014; Hansen et al., 2009; He et al., 2003; Lewis et al., 
2003; Nguyen et al., 2014; Ramani et al., 2009; Rehwinkel, 2005; Tani et al., 2012a). 
While this post-transcriptional gene regulatory feature is clearly important, it is still 
unclear what cis-regulatory features of endogenous NMD targets influence their 
recognition by the NMD pathway. 
 It is well established that the 3’ untranslated region (UTR) can have a major 
influence on the targeting of an endogenous mRNA by NMD. The 3’ UTR of an 
endogenous NMD target attached to a reporter coding sequence is sufficient to render 
that reporter sensitive to NMD activity (Nelson et al., 2016), indicating that the 3’ UTR 
is a major determining factor in NMD target recognition. Most studies to identify mRNA 
characteristics recognized by the NMD machinery have focused on the 3’ UTR. One 
potential feature of endogenous NMD targets may be long 3’ UTRs. An mRNA with a 
PTC would have an artificially long 3’ UTR due to the early termination of translation, 
and this long “faux” 3’ UTR may influence the recognition of PTC-containing mRNAs 
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as NMD targets (Amrani et al., 2004). For this reason, mRNAs encoded with 
endogenous long 3’ UTRs may appear as PTC-containing mRNAs to the NMD pathway 
(Figure 1.2A). Indeed, endogenous NMD targets tend to have longer than average 3’ 
UTRs in both human and Drosophila cells (Chapin et al., 2014; Tani et al., 2012a); 
however, a long 3’ UTR is not sufficient to induce NMD, and some endogenous NMD 
targets have a 3’ UTR that is shorter than average (Chapin et al., 2014; Tani et al., 
2012a). Sequence-specific enhancer and suppressor features have been identified in 3’ 
UTRs of yeast and human mRNAs that can influence the efficiency of NMD targeting 
(Ge et al., 2016; Toma et al., 2015; Zhang et al., 1995). It is likely that these enhancer 
and suppressor elements combined with 3’ UTR length regulate the targeting of 
endogenous NMD targets (Figure 1.2B). 
Many of the same features that cause NMD to target PTC-containing mRNAs 
may also be present in endogenous NMD target 3’ UTRs. One such feature may be the 
presence of an exon-exon junction downstream of the stop site (Figure 1.2C). It is well 
characterized that EJC factors contribute to NMD activity in mammalian cells (Palacios 
et al., 2004); however, the EJC is not required for degradation of all mammalian NMD 
targets (Buhler et al., 2006), and EJC factors are dispensable for NMD in Drosophila 
cells (Gatfield et al., 2003). Although 3’ UTR EJCs may contribute to the recognition of 
endogenous NMD targets, this does not appear to be the only mechanism influencing 
targeting. 
 Splice isoforms that introduce features that mimic a PTC is another mechanism 
that produces endogenous NMD targets (Figure 1.2D). In Drosophila, the long isoform 
of the sex determinant gene transformer is a well-characterized endogenous NMD target 
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(Metzstein and Krasnow, 2006; Rehwinkel, 2005). There are two isoforms of 
transformer: a short isoform (traS), which encodes the Transformer protein, and a long 
isoform (traL), which includes an early exon that introduces an early termination codon 
(Inoue et al., 1990). The early termination codon in the traL mRNA resembles a PTC, 
and the expression of this mRNA is restricted by the NMD pathway, while traS 
expression is not influenced by NMD (Metzstein and Krasnow, 2006). Similar NMD-
dependent degradation of specific alternative splice isoforms has been characterized in 
many human genes as well (Drummond and Friderici, 2013; Panelli et al., 2012; Yan et 
al., 2015). Other NMD targets contain upstream open reading frames (uORFs) as their 
likely source of NMD targeting (Figure 1.2E). Translation termination at an uORF 
would similarly simulate a PTC, causing recognition by the NMD pathway. Up to a half 
of all uORF-containing transcripts in S. cerevisiae and humans are regulated by NMD 
(Malabat et al., 2015; Somers et al., 2013), suggesting this is a common feature of NMD 
targeting. Although these features that simulate PTCs exist in many endogenous NMD 
targets, many other NMD targeted mRNAs do not contain these features, so a more 
general understanding of the RNA characteristics that cause NMD target recognition is 
unknown. 
 One approach to understanding the cis-acting features that influence NMD target 
recognition is to first identify all of the endogenous NMD targets in an organism and 
discovery their commonality. The most frequent method to identify these genes has been 
to use transcriptome profiling (through microarray or RNA-sequencing analysis) of 
NMD mutants or in cells with reduced expression of NMD factors. As previously 
mentioned, inhibition of NMD causes increased expression of a large percentage of the 
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genome in many model systems, including S. cerevisiae, C. elegans, Drosophila, and 
mammalian cells (Barberan-Soler et al., 2009; Chapin et al., 2014; Guan et al., 2006; 
Hansen et al., 2009; He et al., 2003; Lewis et al., 2003; Nguyen et al., 2014; Ramani et 
al., 2009; Rehwinkel, 2005; Tani et al., 2012a). However, not all of the genes that have 
increased expression during NMD inhibition are necessarily endogenous NMD targets, 
as the increased stability of any given endogenous NMD target is likely to have 
downstream effects that lead to the transcriptional increase of other secondary genes. 
This possibility makes it impossible to distinguish direct endogenous targets from those 
secondary targets by simply detecting the genes with increased expression in cells 
lacking NMD function. 
 Several efforts have been made to parse the direct endogenous targets from those 
secondary targets with increased expression during NMD inhibition. One approach has 
been to use RNA cross-linking immunoprecipitation to detect mRNAs that bind NMD 
factors. The difficulty in this approach has been that the interactions between most NMD 
factors and their targets are too transient for cross-linking to pull down RNAs bound to 
these proteins. RNAs that bind Upf1 in mouse cells have been successfully detected 
using this technique (Hurt et al., 2013). This study found Upf1 bound approximately 200 
mRNAs, most of which have increased expression during loss of NMD activity (Hurt et 
al., 2013). These NMD targets again tended to have 3’ UTRs that were longer than 
average, but some short 3’ UTR targets were identified (Hurt et al., 2013). 
 An alternative approach to identify endogenous NMD targets was to characterize 
the stability of mRNAs when NMD is either active or inactive at a genome-wide scale. 
BRIC-seq is a method to pulse label mRNAs with 5’-bromo-uridine (BrU) followed by 
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immunoprecipitation of BrU-incorperated mRNAs at time points following pulse 
labeling, and sequencing of these mRNAs to measure the decrease in their abundance 
over time without the use of transcriptional inhibitors (Tani et al., 2012b). Using this 
technique in HeLa cells with active NMD and Upf1 inhibited cells identified over 700 
mRNAs that are degraded in a UPF1-dependent manner (Tani et al., 2012a). 
Interestingly, only around 10% of these mRNAs had increased expression in the Upf1 
inhibited cells (Tani et al., 2012a). Additionally, only a small portion of the mRNAs with 
increased expression in Upf1 inhibited cells had Upf1-dependent decay (Tani et al., 
2012a), indicating that the majority of genes whose expression is influenced by NMD 
are not endogenous NMD targets. Another study that measured genome-wide Upf2-
dependent mRNA decay in Drosophila found a similar phenomenon. Measuring the 
abundance of mRNAs on a time course after expression of wild-type Upf2 in Upf2 
mutant Drosophila discovered a set of mRNAs that quickly reduced cellular abundance 
following expression of wild-type Upf2 (Chapin et al., 2014). These mRNAs with 
quickly reduced expression are likely direct endogenous NMD targets, explaining why 
they are the first set of mRNAs to have their expression reduced. Interestingly, only a 
small subset of the mRNAs with increased expression in Upf2 mutants had quickly 
reduced abundance upon expression of wild-type Upf2 (Chapin et al., 2014). 
Additionally, a similarly small amount of those genes that are likely endogenous NMD 
targets have increased expression in Upf2 mutants (Chapin et al., 2014). Transcriptional 
inhibition in Upf1+ and Upf1Δ yeast strains also identified that only about a third of 
genes with increased expression in the Upf1Δ strain had Upf1-dependent decay (Guan et 
al., 2006), indicating that a minority of genes repressed by NMD are actually NMD 
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targets in general. These similar findings in multiple organisms suggest that many of the 
endogenous NMD targets have additional regulatory factors that maintain their 
expression during loss of NMD activity. This discovery may explain the mRNAs bound 
by Upf1 that do not have increased expression during NMD inhibition.  
Both the Drosophila and human cell line studies to identify endogenous NMD 
targets discovered that these mRNAs tend to have longer than average 3’ UTRs (Chapin 
et al., 2014; Tani et al., 2012a). While average 3’ UTR length was the only difference 
between endogenous NMD targets and non-targeted mRNAs identified in these studies, 
3’ UTR length did not completely account for the targeting of these mRNAs. Many 
endogenous targets had UTRs shorter than average, and many mRNAs with long UTRs 
were not targeted, consistent with the notion that there are other modifiers that can 
influence NMD targeting that were not accounted for in these studies. 
 While NMD has widespread effects on gene expression, many questions about 
endogenous NMD targets still remain. Although the approaches described here 
discovered many endogenous NMD targets, these methods have a low sensitivity and 
likely failed to detect many other endogenous targets. Additionally, these studies did not 
reveal an insight into the function of the regulation of endogenous mRNAs by NMD. 
Understanding both the targets regulated by NMD and the biological features of that 
regulation may reveal important features of NMD as a gene regulatory mechanism. 
 
Endogenous NMD Targets: Why Are  
They Regulated by NMD? 
 While much is known about how the NMD pathway distinguishes endogenous 
NMD targets from non-target mRNAs, very little is understood about the purpose of this 
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mechanism of post-transcriptional gene regulation. In many organisms, NMD is required 
for viability, suggesting that the NMD pathway is regulating some biological process 
with critical influence on development (Frizzell et al., 2012; Kerényi et al., 2008; Li et 
al., 2015; McIlwain et al., 2010; Medghalchi et al., 2001; Metzstein and Krasnow, 2006; 
Thoren et al., 2010; Weischenfeldt et al., 2008; Wittkopp et al., 2009). However, less 
complex organisms such as C. elegans and yeast do not require NMD activity for 
viability, indicating that the process required to be regulated by NMD in more complex 
organisms is not regulated by NMD in these animals (Hodgkin et al., 1989; Leeds et al., 
1991). Since NMD represses the expression of both PTC-containing mRNAs and 
endogenous NMD targets, it is unclear which class of NMD target is the cause of this 
lethality (Hwang and Maquat, 2011).  
This difference in the requirement for NMD may reveal some feature of the 
NMD pathway that is different between the two groups of species. One possibility may 
be that the more complex organisms have greater opportunity for PTC-containing 
mRNAs to be produced. However, the C. elegans genome contains more protein coding 
genes than the Drosophila genome (Hillier et al., 2005; Lin et al., 2007), so a potential 
difference in PTC-abundance could not be explained by differences in number of loci 
alone. It may be possible that those organisms that require NMD function are more 
sensitive to the existence of spontaneously produced PTCs than those that do not require 
NMD. While there is no direct evidence that PTC-containing mRNAs are the cause of 
lethality in NMD mutants, loss of the surveillance feature of NMD may contribute to its 
requirement for viability. 
 Alternatively, the death of animals lacking NMD function may be due to 
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increased stability, and thus subsequent increased protein expression, of endogenous 
NMD targets. It is possible that some endogenous NMD targets may have functions that 
could influence development and viability, and the stabilization and subsequent 
increased expression of these mRNAs would be lethal. These targets causing lethality 
may not be expressed, or may not be regulated by NMD in C. elegans and yeast, which 
would explain why NMD is not required for viability in these animals. In Arabidopsis, 
NMD degrades the mRNAs encoding a subset of immune-related intracellular 
nucleotide-binding leucine-rich repeat receptors that can promote cell death, and 
blocking the transcription of these receptors restores viability to NMD mutants 
(Gloggnitzer et al., 2014), suggesting they contribute to lethality in plants lacking NMD 
activity. However, no endogenous target in any animal has yet to be shown to influence 
viability. 
 While it is unclear how NMD is required for viability, the function of the 
degradation of endogenous NMD targets has been well characterized in a few cases. 
MAC1 is a transcription factor that regulates the expression of genes involved in copper 
transport in S. cerevisiae, which is targeted by NMD in rich media, but is resistant to 
NMD in low copper media, leading to increased expression (Peccarelli et al., 2016). It is 
unclear how the MAC1 transcript becomes resistant to NMD in low copper, but it is 
likely due to changes in RNA structure that may occur under this different cellular 
condition. Additionally, two NMD factors themselves, Smg5 and Smg6, are endogenous 
NMD targets in both Drosophila and mammalian cells (Chapin et al., 2014; Tani et al., 
2012a), suggesting a potential negative feedback loop to regulate NMD activity itself. 
 While NMD-mediated gene regulation can be used to produce feedback loops 
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like those described above, targeting of mRNAs by NMD could also be used to limit the 
number of proteins produced by any given mRNA. It may be beneficial for the cell to 
tightly correlate the number of proteins made to the number of mRNAs of a given gene 
in some cases. For example, the mRNA for the mammalian post-synaptic regulator 
Activity-regulated cytoskeletal-associated protein (arc) is an endogenous NMD target, 
due to having two exon-exon junctions in its 3’ UTR (Giorgi et al., 2007). Arc mRNA 
localizes to dendritic segments and is translated in response to induction of long-term 
potentiation (Rodríguez et al., 2005; Steward et al., 1998). Given the precise spatial and 
temporal regulation of arc translation, it is likely that degradation of arc mRNA by 
NMD quickly after translation helps maintain this tight regulation (Bramham et al., 
2008).  
One long-standing question has been whether NMD is differentially required in 
different tissues or during different stages in development. Loss of Upf1 or Upf2 causes 
early lethality during mouse embryogenesis, so NMD appears to be critical for these 
early developmental stages (Medghalchi et al., 2001; Weischenfeldt et al., 2008). Tissue-
specific ablation of Upf2 in the liver, hematopoietic precursors, or Sertoli cells in the 
testis leads to almost complete loss of these tissues (Bao et al., 2015; Thoren et al., 2010; 
Weischenfeldt et al., 2008). Although NMD is required for development of all of these 
tissues tested, reduction in NMD activity has varying effects on the compensatory 
increase of NMD factors in different tissues (Huang et al., 2011), indicating there may be 
varying requirements for NMD between these cell types. Interestingly, NMD is actually 
inhibited in the nervous system during mouse development. miRNA-128 is expressed in 
the brain beginning at embryonic day 9.5, increases during postnatal development, and 
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persists during adulthood (Bruno et al., 2011). miRNA-128 targets the Upf1 mRNA and 
inhibits UPF1 expression (Bruno et al., 2011), promoting expression of genes required 
for neural differentiation. This study suggests that inhibition of NMD may be an 
important aspect of development in some contexts, and indicates that NMD has varying 
requirements in tissue specific context.  
Understanding the requirement of NMD for viability will be necessary to 
understand the potential tissue specific functions of NMD. Determining if the 
surveillance or gene regulatory NMD function is the feature required for viability is also 
important to understand the contributions of this pathway. This dissertation will 
approach the understanding of the requirement of NMD for viability and other biological 
functions in Drosophila. 
 
Clinical Importance of NMD 
 NMD activity can have a very strong influence on disease. Although NMD 
serves to degrade PTC-containing mRNAs, there are many alleles in the population that 
produce PTCs that evade NMD. These NMD evading alleles can uniquely influence 
disease in one of three ways: (1) create a dominant disease inheritance, (2) produce more 
severe disease symptoms, or (3) have reduced disease severity (Bhuvanagiri et al., 2010; 
Khajavi et al., 2006; Miller and Pearce, 2014). These types of alterations to disease 
inheritance and severity are defined by the differences that occur between PTC alleles 
located in the 5’ region of a gene that are degraded by NMD and PTC alleles in the 3’ 
region of the same gene that evade NMD. In the case of alleles that produce dominant 
disease inheritance, the 5’ alleles degraded by NMD have no effect as a heterozygote, 
but cause disease in a recessive manner when inherited as a homozygote. 3’ PTC alleles 
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in the same gene that are not degraded by NMD instead cause the same disease as a 
heterozygote, and thus are inherited in a dominant way (Figure 1.3A). Mutations in the 
ß-Globin encoding gene HBB have these varied inheritance patterns due to differences in 
NMD targeting (Hall and Thein, 1994). 
 In addition to influencing the inheritance pattern of a disease, PTC-inducing 
alleles that evade NMD can also cause more severe disease symptoms than PTC alleles 
in the same gene that are degraded by NMD. This phenomenon usually occurs with 
genes where haploinsufficiency during heterozygous loss of function leads to disease. In 
these cases, individuals heterozygous for a PTC-inducing allele that is degraded by 
NMD have disease, but individuals for a PTC allele in the same gene not degraded by 
NMD have more severe disease symptoms (Figure 1.3B). These more severe symptoms 
can manifest either as a more intense condition of disease symptoms, such as with 
mutations in COL1A1 (Körkkö et al., 1998; Willing et al., 1996), or they can manifest as 
completely different symptoms, like with mutations in SOX10 or ELN (Inoue et al., 
2004; Tassabehji et al., 1997). In these conditions where more severe disease symptoms 
or dominant inheritance occur due to alleles evading NMD, it may be beneficial to 
bolster NMD activity to degrade these NMD-insensitive alleles. Understanding the 
mechanisms of NMD targeting and decay can help provide tools to increase NMD 
activity in these patients. 
 Although enhancing NMD activity may be a therapy for the diseases described in 
these first two ways that NMD can alter disease severity and inheritance, NMD may also 
degrade PTC-containing mRNAs that would produce proteins that are not harmful. In 
these cases, alleles that evade NMD could potentially produce a truncated protein that 
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may maintain some function. Individuals homozygous for PTC-inducing alleles that are 
degraded by NMD would have complete loss of function, which may cause disease, but 
those homozygous for NMD-evading alleles may have reduced disease severity because 
of the partially functional protein (Figure 1.3C). In fact, this phenomenon occurs in 
cases of muscular dystrophy with alleles of DMD (Kerr et al., 2001) and cystic fibrosis 
with CFTR alleles (Rowntree and Harris, 2003). It is likely that there are many other 
genes in which NMD-evading PTC alleles have reduced disease severity compared to 
alleles of the same gene that are degraded by NMD, but they are uncharacterized because 
they do not have any symptoms. 
 Since PTC-alleles that evade NMD may have suppressed disease symptoms 
compared to those alleles degraded by NMD, NMD inhibition may be an effective 
therapy for individuals suffering from loss-of-function genetic diseases. NMD inhibition 
would stabilize PTC-containing mRNAs normally degraded by NMD, allowing them to 
produce partially functional proteins that could suppress, and potentially eliminate, 
disease symptoms (Figure 1.3D). Additionally, combining NMD-inhibition with stop 
codon read-through could potentially not only stabilize these mRNAs, but also produce 
full-length proteins, which would be very likely to eliminate disease symptoms 
completely (Keeling and Bedwell, 2011). Considering that up to a third of genetic 
diseases are due to loss-of-function PTC alleles (Khajavi et al., 2006), a general therapy 
for these diseases would be an effective treatment for a wide range of patients suffering 
from both common diseases and rare diseases for which therapies might not otherwise be 
developed. However, given that loss of NMD activity causes lethality in most model 
systems, NMD inhibition has not been heavily pursued as a therapy option given the 
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high likelihood of harmful side effects, and no NMD inhibitors have been tested in 
humans (Bhuvanagiri et al., 2010). Discovering the cause of the lethality in animals 
lacking NMD activity may allow for a way to subvert the potential harmful effects from 
NMD inhibition and the development of this therapy. 
  
Conclusions 
 While there are many different mechanisms to regulate mRNA stability, the 
nonsense-mediated mRNA decay pathway functions both as a regulator of gene 
expression and as a quality-control mechanism in the cell. Understanding how the NMD 
pathway identifies and degrades its targets is important for understanding both the 
maintenance of mRNA quality in the cell, and for understanding the regulation of gene 
expression. Although many of the molecular interactions of NMD have been well 
characterized, genetic understanding of the relative contribution of each NMD factor is 
lacking. By using genetics to uncover the function of each NMD factor, we can better 
model the role of the complex as a whole. Making these discoveries also has important 
clinical implications, as modifying NMD activity could serve as a therapy for a wide 
range of both rare and common genetic diseases. This dissertation presents my work to 
uncover the biological role NMD gene regulation has in development and maintaining 




Figure 1.1. The canonical model of the NMD mechanism. (A) Translation initiates at 
the start codon and terminates at a premature termination codon (PTC). Upon translation 
termination, eRF3 (red triangle) binds the ribosome. When translation terminates at a 
PTC, Upf1 binds eRF3, stabilizing Upf1 binding target mRNA. The NMD factor Upf3 is 
bound to exon junction complexes (EJCs) at exon-exon junctions (black line). EJCs 
bound to exon-exon junctions upstream of the PTC are removed during translation, but 
those downstream of the PTC remain. (B) Upf2 binds both Upf1 and Upf3, bridging 
these factors and stabilizing the NMD complex on the target mRNA. (C) Smg1 binds 
Upf1 and phosphorylates (yellow star) it at multiple residues in the C-terminal and N-
terminal ends. (D) The endonuclease Smg6 and a heterodimer of Smg5 and Smg7 binds 
phosphorylated Upf1 residues. The Smg5/7 heterodimer also binds the phosphatase 
PP2A to recruit it to the NMD complex. (E) Smg6 cleaves the target mRNA near the 
PTC. PP2A dephosphorylates Upf1, which allows for complex disassembly. The general 
5’-to-3’ and 3’-to-5’ exonucleases can degrade the mRNA at the now exposed 5’ end 










































Figure 1.2. cis-acting features of endogenous NMD targets. (A) Many endogenous 
NMD targets contain a long 3’ untranslated region (UTR), while a short 3’ UTR is 
usually unrecognized by NMD. (B) The presence of sequence-specific NMD enhancer 
elements (yellow) in the 3’ UTR can stimulate NMD, even when in a short 3’ UTR that 
might otherwise not be recognized by NMD. Sequence-specific NMD repressor elements 
(orange) in the 3’ UTR can reduce targeting by NMD, even when in a long 3’ UTR that 
may otherwise be recognized by NMD. (C) An exon junction complex (EJC, purple 
circle) found on an exon-exon junction (black bar) in the 3’ UTR can induce NMD 
targeting. EJCs are removed from exon-exon junctions in the 5’ UTR and open reading 
frame during translation, and thus those junctions do not stimulate NMD targeting. (D) 
Alternative splice sites that incorporate an early termination codon can induce NMD 
when exclusion of the termination-codon-containing exon may cause no NMD targeting. 
(E) An upstream open reading frames (uORF) located in the 5’ UTR is frequently 
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Figure 1.3. NMD can modulate disease inheritance and severity. (A) NMD-evading 
PTC alleles can cause dominant disease inheritance. Recessive disease-causing PTC 
alleles degraded by NMD do not produce disease as a heterozygote, but only when both 
copies are lost. NMD-evading alleles of the same gene produce truncated proteins that 
cause disease as a heterozygote, making a normally recessively inherited disease 
dominantly inherited.. (B) NMD-evading PTC alleles can cause more severe disease 
symptoms than alleles degraded by NMD. Haploinsufficiency of a gene with a single 
PTC allele causes dominantly inherited disease. NMD-evading alleles of the same gene  
produce truncated proteins that can cause more severe, or additional, symptoms than 
those resulting from haploinsufficiency. (C) NMD-evading alleles can have less severe 
disease symptoms than complete loss of function due to homozygous PTC mutations that 
are degraded by NMD. Homozygous PTC alleles can cause recessive loss-of-function 
disease. NMD-evading alleles can produce truncated proteins that maintain some protein 
function, which has less severe symptoms than complete loss of function. (D) Inhibition 
of NMD may restore stability to PTC containing mRNAs in loss-of-function genetic 
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Abstract The nonsense-mediated mRNA decay (NMD) pathway functions to degrade both
abnormal and wild-type mRNAs. NMD is essential for viability in most organisms, but the molecular
basis for this requirement is unknown. Here we show that a single, conserved NMD target, the
mRNA coding for the stress response factor growth arrest and DNA-damage inducible 45
(GADD45) can account for lethality in Drosophila lacking core NMD genes. Moreover, depletion of
Gadd45 in mammalian cells rescues the cell survival defects associated with NMD knockdown. Our
findings demonstrate that degradation of Gadd45 mRNA is the essential NMD function and,




Maintaining proper gene expression is critical for normal development and physiology. In addition
to de novo transcription, mRNA stability substantially contributes to forming the landscape of
expression in a cell. The nonsense-mediated mRNA decay (NMD) pathway is a trans-acting mecha-
nism that destabilizes mRNAs, and is best known for its well-described role as a quality control sys-
tem, degrading abnormal mRNAs containing premature termination codons (PTCs) (Celik et al.,
2015). NMD also degrades many wild-type endogenous mRNAs and thus is an important aspect of
their post-transcriptional (Peccarelli and Kebaara, 2014). Loss of either of the core NMD genes
Upf1 (Rent1) or Upf2 causes lethality in most eukaryotes (Kere´nyi et al., 2008; Medghalchi et al.,
2001; Metzstein and Krasnow, 2006; Weischenfeldt et al., 2008; Wittkopp et al., 2009), indicat-
ing regulation of mRNA stability by NMD is critical for viability. However, the relative contributions
to lethality from ectopic stabilization of PTC-containing mRNAs or endogenous NMD targets in
NMD mutants remains unclear (Hwang and Maquat, 2011).
To identify which ectopically stabilized mRNAs are responsible for inducing lethality in NMD
mutants, we performed an unbiased genetic suppressor screen seeking to restore viability in a Dro-
sophila NMD mutant. To detect subtle increases in survival, we screened to suppress the lethality of
animals mutant for the partially viable, hypomorphic Upf225G allele, of which 10% survive to adult-
hood (Chapin et al., 2014; Metzstein and Krasnow, 2006). We crossed this allele to heterozygous
deficiencies to simultaneously reduce the mRNA abundance of several loci (Figure 1A). Of the 376
deficiencies tested, covering more than half the genome, ~10% suppressed NMD mutant lethality
(Figure 1B, Figure 1—figure supplement 1A). The suppression effect could not be explained by a
reduction in overall mRNA load, as there was only a weak correlation between the increase in
mRNAs expressed from a genomic region upon loss of NMD function and the strength of
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suppression when that region was removed by a deficiency (Figure 1—figure supplement 1B).
Rather, deficiencies that suppressed NMD-mutant lethality clustered in three genomic regions (Fig-
ure 1—figure supplement 1A). These findings suggest that NMD mutant lethality is not the result
of a global excess of nonspecific mRNAs, but rather is mediated by specific genes residing within
the few identified regions.
We expected that any specific genes mediating NMD-mutant lethality would have increased
expression levels in an NMD mutant and be a direct NMD target. The only gene located within the
suppressing regions to fit these criteria is Gadd45 (Figure 1C, Figure 1—figure supplement 2A–C)
(Chapin et al., 2014). To determine if NMD targeting of Gadd45 mRNA is critical for viability, we
generated a Gadd45 null allele, F17, which completely removes the Gadd45 coding region (Fig-
ure 1—figure supplement 3A) and eliminates Gadd45 mRNA expression (Figure 1—figure supple-
ment 2A). As a heterozygote, Gadd45F17 suppressed Upf225Glethality as strongly as the
corresponding deficiency identified by our screen (Figure 1D). We found that Gadd45F17 homozy-
gous mutants are fully viable (Figure 1—figure supplement 3B), allowing us to test complete loss of
Gadd45 for the suppression of NMD-mutant lethality. Homozygous Gadd45F17 restored full viability
to Upf225Gmutants, and remarkably even partially suppressed the complete lethality observed in null
Upf1 and Upf2 mutants (Frizzell et al., 2012; Metzstein and Krasnow, 2006) (Figure 1D). Impor-
tantly, neither reducing nor eliminating Gadd45 restored NMD function to Upf225G mutants, as mea-
sured by the expression of both an endogenous NMD target (Figure 1—figure supplement 4A)
and PTC-containing mRNAs (Figure 1—figure supplement 4B).
In mammals, GADD45 activates the MTK1/MEKK4 kinase in a well-defined stress response path-
way (Takekawa and Saito, 1998). Strikingly, the Drosophila MTK1 orthologue, Mekk1, resides within
another Upf225G suppressing region (Figure 1E). Similar to Gadd45, we found that Mekk1 null
mutants (Inoue et al., 2001) suppressed Upf1 and Upf2 mutant lethality (Figure 1F). This suppres-
sion was not as strong as that caused by a loss of Gadd45, revealing that although MEKK1 mediates
eLife digest Messenger RNA (mRNA) molecules act as the templates from which proteins are
made, and so control the amount of protein in a cell. Having too much of certain proteins can harm
cells. Additionally, some mRNAs contain errors, and so can create faulty proteins that may also harm
the cell.
Cells have therefore developed ways to destroy excess or error-ridden mRNAs to avoid a deadly
build up of proteins. One such quality control mechanism is called nonsense-mediated decay (NMD).
This mechanism is so important that cells that cannot perform nonsense-mediated decay die,
although it is not clear exactly what kills the cells.
Now, Nelson et al. have found that fruit flies whose cells are unable to perform nonsense-
mediated decay die because a harmful protein called Gadd45 builds up in the cells. In normal cells,
nonsense-mediated decay destroys the mRNA that relays the instructions for making Gadd45, which
keeps the amount of the Gadd45 protein in the cell low. Further experiments show that removing
Gadd45 from cells that lack nonsense-mediated decay saves the flies. Removing Gadd45 from
human and mouse cells that are unable to perform nonsense-mediated decay also allows these cells
to survive.
These findings imply that the only nonsense-mediated decay function needed for cells to live is
the destruction of Gadd45 mRNA. This further implies that most faulty and normal mRNAs that are
normally destroyed by nonsense-mediated decay do not cause the cells to die when nonsense-
mediated decay is lost.
Learning that creating faulty proteins when nonsense-mediated decay is lost is not necessarily
harmful to cells opens new possibilities to treating numerous genetic diseases. In some diseases,
cells can only produce faulty forms of a particular protein. Nonsense-mediated decay normally
destroys all of these mutant proteins, but it may sometimes be better to have faulty versions of a
protein than to have none of it. Safely getting rid of nonsense-mediated decay by also eliminating
Gadd45 from cells may therefore be a treatment strategy worth exploring.
DOI: 10.7554/eLife.12876.002
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Figure 1. Drosophila suppressor screen identifies the Gadd45 pathway as the inducer of NMD-mutant lethality. (A) Scheme to screen deficiencies for
the suppression of Upf225G partial lethality. The Deficiency Suppression Score (DSS) represents the relative difference in Upf225G viability when crossed
to a heterozygous deficiency (Df) compared to when crossed to a balancer (Bal) (See Methods). (B) DSS from 376 screened deficiencies ranked by score.
A DSS greater than 0.1 (dotted line) indicates that deficiency suppresses Upf225G lethality. (C and E) Candidate suppressing regions uncovering Gadd45
(C) and Mekk1 (E). DSSs are shown in parenthesis. Dotted lines denote extent of regions deleted by suppressing deficiencies but not non-suppressing
deficiencies. Filled blocks on chromosomes indicate predicted gene spans, Gadd45 pathway genes are indicated in red; suppressing deficiencies
indicated in green, sple-J1 has undefined breakpoints located within hashed regions. (D and F) NMD mutant adult viability in combination with
Gadd45F17 (D) or Mekk1Ur36 (F) mutants. Upf126A and Upf27-5A are null alleles (Frizzell et al., 2012; Metzstein and Krasnow, 2006). p-value compared
to controls determined by the test of equal or given proportions indicated. Error bars represent 95% confidence interval of the binomial distribution. n
equals total number of animals scored in each cross.
DOI: 10.7554/eLife.12876.003
The following figure supplements are available for figure 1:
Figure supplement 1. Reduced expression of specific loci, not overall mRNA abundance, produces NMD mutant suppression by deficiencies.
DOI: 10.7554/eLife.12876.004
Figure supplement 2. Drosophila Gadd45 is an endogenous direct NMD target.
Figure 1 continued on next page
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NMD mutant lethality, it is likely that GADD45 has additional downstream effectors that influence
viability. Overall, our findings reveal that increased Gadd45 mRNA stability is the major factor induc-
ing NMD mutant lethality, primarily via increased MEKK1 activity.
Activation of MTK1 in mammals triggers a MAPK signaling cascade that promotes apoptosis
(Takekawa and Saito, 1998). Over-expression of Gadd45 in Drosophila also induces apoptosis
(Peretz et al., 2007). Interestingly, Drosophila cells lacking NMD function show excess cell death in
a variety of tissues (Avery et al., 2011; Frizzell et al., 2012; Metzstein and Krasnow, 2006). To
test if increased Gadd45 contributes to this excess death, we used TUNEL staining to examine cell
death in wing imaginal discs from Upf225G mutant third instar larvae. This analysis revealed elevated
levels of cell death compared to controls (Figure 2A, B, E), and this defect was completely sup-
pressed by Gadd45F17 (Figure 2C–E). To confirm that, this effect was not specific to the Upf2 gene
or 25G allele, we examined the wing discs in mutants of another essential NMD gene, Smg5. We
found that Smg5 discs also showed elevated TUNEL signal, which was eliminated by loss of Gadd45
(Figure 2—figure supplement 1A–E). These results demonstrate that excess Gadd45 accounts for
ectopic cell death in NMD mutant tissues.
To test if Gadd45-induced cell death is the only cellular defect in NMD mutants, we examined
NMD function in the developing eye. NMD is required for proper development of eye cells, as clonal
patches of NMD mutant cells in eyes are reduced in size (Frizzell et al., 2012; Metzstein and Kras-
now, 2006). We found that Gadd45 is partially responsible for this defect, as the size of eye-cell
clones lacking NMD activity in a Gadd45F17 background was increased, although not fully restored
(Figure 2F–J). These results indicate that some, but not all, defects associated with loss of NMD are
dependent on Gadd45.
Gadd45 is one of the few genes that is directly regulated by NMD in both flies and mammals
(Huang et al., 2011; Tani et al., 2012; Viegas et al., 2007), raising the possibility that excess
Gadd45 abundance may also contribute to the NMD-mutant lethality observed in mammalian cells
(Azzalin and Lingner, 2006; Li et al., 2015; Medghalchi et al., 2001; Weischenfeldt et al., 2008).
To test this hypothesis, we analyzed the effects of Gadd45 and Upf1 depletion in mouse NIH-3T3
cells. Gadd45b mRNA (also known as MyD118), which is expressed at least 10-fold higher than any
other Gadd45 paralogue in these cells (Yue et al., 2014), was degraded rapidly in a partially Upf1-
dependent manner after transcription was blocked with actinomycin D (Figure 3A), and had
increased expression during Upf1 knockdown (Figure 3D), confirming it is sensitive to NMD. We
found that transfection of 3T3 cells with siRNAs targeting Upf1 resulted in significant reduction in
cell counts after 48 hr (Figure 3B), but co-transfection with siRNAs targeting both Upf1 and
Gadd45b largely reversed this effect (Figure 3B). The reduction in cell counts was primarily due to
increased cell death, as we found that ~25% of cells transfected with Upf1 siRNA were undergoing
apoptosis (Figure 3C). Co-transfection of siRNA targeting Gadd45b almost entirely eliminated this
increase (Figure 3C), indicating the excess apoptosis observed in Upf1-knockdown cells was mostly
due to increased Gadd45 activity. However, while Gadd45b knockdown very greatly suppresses this
excess death, it does not as fully rescue cell numbers, suggesting loss of NMD may lead to both
Gadd45b-dependent cell death as well as a Gadd45b-independent effect on proliferation. This mir-
rors the conclusions we made about the partial suppression of cell number defects in the Drosophila
eye. Importantly, Upf1 mRNA expression was equivalently reduced and the expression of the mam-
malian endogenous NMD targets Rassf1 and CRCP (Tani et al., 2012) was equivalently increased in
both the single and double knockdown experiments (Figure 3D), indicating that the restoration of
viability was not due to a recovery of NMD pathway activity.
To extend our analysis to other mammalian cells, we analyzed the role of Gadd45 mediating the
effects of loss of NMD in HEK293 cells. We found, similarly to 3T3 cells, that siRNA knockdown of
UPF1 in HEK293 cells led to increased GADD45A expression and reduced cell numbers compared
Figure 1 continued
DOI: 10.7554/eLife.12876.005
Figure supplement 3. F17 is a null allele of Gadd45.
DOI: 10.7554/eLife.12876.006
Figure supplement 4. Loss of Gadd45 does not restore NMD activity in NMD mutants.
DOI: 10.7554/eLife.12876.007
Nelson et al. eLife 2016;5:e12876. DOI: 10.7554/eLife.12876 4 of 13
Short Report Cell biology
! 45!
to control siRNA (Figure 3—figure supplement 1A,B). Although transfection of siRNA targeting
GADD45A alone slightly reduced HEK293 cell numbers, co-transfection with UPF1 siRNA did not fur-
ther reduce cell count (Figure 3—figure supplement 1B), and UPF1 expression was equivalently
reduced in the single and double knockdown conditions (Figure 3—figure supplement 1C). These
results suggest that UPF1 knockdown is no longer detrimental to HEK293 cell viability in the absence
of GADD45A expression. We conclude that increased expression of mammalian Gadd45 genes con-
tributes to lethality in NMD-deficient mouse and human cells, as Gadd45 does in Drosophila.
Deconvoluting the contributions to organismal viability of the PTC-surveillance versus gene-regu-
latory functions of NMD has been historically difficult (Hwang and Maquat, 2011). Here, we show
that viability can be restored to Drosophila lacking core NMD factors when a single endogenous
Figure 2. Loss of Gadd45 suppresses NMD-mutant cell death. (A to D) DAPI (blue) and (A’to D’) TUNEL (red)
staining in late 3rd instar larval wing discs from control (A); Upf225G (B); Gadd45F17 (C); and Upf225G; Gadd45F17 (D)
animals. (A’’ to D’’) are 4x view of outlined section at the base of the blade of the wing disc from A’-D’,
respectively. Scale bar represents 100 mm. (E) Relative TUNEL signal in control and mutant wing discs, normalized
to control. p-value between indicated samples using a two-sided Student’s t-test are displayed. ns indicates a p-
value greater than 0.05. Error bars represent 2 SEM. n equals total number of discs scored. (F to I) w- eye clones in
Gadd45+ and Gadd45F17 backgrounds. Dashed lines indicate clone boundaries. (J) Quantification of the fraction of
the eye composed of w- cells in control and mutant eyes. p-values indicate differences between Gadd45 mutant
and control in the same NMD background (indicated by horizontal bars) or NMD mutant and control in the same
Gadd45 background (indicated by value above each individual bar), using a two-sided Student’s t-test. ns
indicates a p-value greater than 0.05. Error bars represent 2 SEM. n = 20 eyes for all conditions.
DOI: 10.7554/eLife.12876.008
The following figure supplement is available for figure 2:
Figure supplement 1. Loss of Gadd45 suppresses ectopic cell death in Smg5 mutant wing discs.
DOI: 10.7554/eLife.12876.009
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NMD target, Gadd45, is eliminated, and that the requirement for the regulation of Gadd45 by NMD
is evolutionarily conserved from flies to mammals. Although our data suggest that up-regulation of
Gadd45 is a major factor contributing to lethality when NMD activity is lost, it is likely that other
NMD targets also contribute to the observed lethality. In particular, viability is not restored to 100%
in null Upf1; or Upf2; Gadd45 double mutants. In addition, loss of Gadd45 suppresses programmed
cell death caused by defects in NMD, but not additional cell cycle defects, as implied by the incom-
plete suppression in the Drosophila eye and mammalian cell culture. Such defects in the cell cycle
may be particularly pronounced during the development of certain tissue, or specific developmental
stages. Indeed, NMD has been reported to have differing stage and tissue- specific activities
(Bao et al., 2015; Bruno et al., 2011; Colak et al., 2013; Li et al., 2015). Whether this is due to a
role in surveillance or another specific target remains unclear, but examination of the effects of loss
of NMD in Gadd45 mutants should allow exploration of these possibilities.
The benefit for such a mechanism regulating Gadd45 expression may lie in a function of NMD in
restricting viral growth (Balistreri et al., 2014). Because viruses encode trans-acting factors to inhibit
NMD (Mocquet et al., 2012), the resulting accumulation of GADD45 in infected cells may act as a
Figure 3. Gadd45b mediates cell lethality in Upf1 siRNA knockdown 3T3 mouse embryonic fibroblasts. (A) Relative Gadd45b mRNA expression
measured by qRT-PCR in NIH-3T3 cells after 48 hr of control (black) or Upf1 (red) siRNA treatment and 0 to 2 hr of actinomycin D treatment, normalized
to expression prior to actinomycin treatment. The half-life calculated for each decay curve is indicated. (B) Relative viable cell count of Upf1 and
Gadd45b single and double siRNA treatment normalized to control siRNA. p-values display two-sided Student’s t-test between indicated conditions.
(C) Quantification of apoptosis as measured by annexin V staining. p-values display two-sided Student’s t-test between indicated conditions. (D)
Relative mRNA expression of Upf1, Gadd45b, and two mammalian endogenous NMD targets, Rassf1 and CRCP (Tani et al., 2012) measured by qRT-
PCR in Gadd45b and Upf1 single and double siRNA knockdown cells, normalized to expression in the control siRNA condition. p-values display one-
sided Student’s t-test for each condition compared to control. Error bars represent 2 SEM.
DOI: 10.7554/eLife.12876.010
The following figure supplement is available for figure 3:
Figure supplement 1. GADD45A mediates cell lethality in Upf1 knockdown HEK293 cells.
DOI: 10.7554/eLife.12876.011
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“molecular tripwire” that rapidly elicits a stress response and cell death. This outcome suggests that
regulating responses to infection may underlie a conserved essential function of NMD. Intriguingly,
restriction of pathogens via NMD extends to plants (Garcia et al., 2014), where NMD mutant lethal-
ity in A. thaliana, which do not encode Gadd45 orthologues, may be caused by the overexpression
of a subset of immune-related intracellular nucleotide-binding leucine-rich repeat receptors, some of
which are endogenous NMD targets (Gloggnitzer et al., 2014). In contrast, eukaryotes that do not
rely on the activation of programmed cell death to protect against viruses, such as S. cerevisiae, S.
pombe, and C. elegans, do not require NMD for viability (Hodgkin et al., 1989; Leeds et al., 1991;
Mendell et al., 2000). Together these observations suggest a potential novel role for NMD and
Gadd45 in immune responses, triggering the death of infected cells during pathogenic challenges.
Restoring the expression of PTC-containing alleles via NMD inhibition has been proposed as a
promising therapy for a wide range of recessive genetic diseases (Keeling et al., 2014). Translation
of stable PTC-containing mRNAs would produce truncated proteins that may be partially functional
and alleviate disease symptoms normally caused by complete loss of the protein. However, the
essential function for NMD in viability has raised the concern that these therapies may have prohibi-
tive side effects. Our findings reveal a molecular basis for dealing with this obstacle by suggesting
that inhibiting both the NMD and Gadd45 pathways (Tornatore et al., 2014) in combination could
provide an effective and safe treatment for patients with debilitating genetic disorders.
Materials and methods
Fly genetics
Drosophila melanogaster stocks were raised on standard cornmeal/dextrose food at 25˚. The NMD
mutant alleles Upf225G, Upf27-5A, and Upf126A (Frizzell et al., 2012; Metzstein and Krasnow, 2006)
are on y w FRT19A chromosomes. These alleles were balanced over FM7i, P{ActGFP}JMR3
(Reichhart and Ferrandon, 1998). Smg5G115 and Smg5C391 are null alleles of Smg5 (J.O.N., D. Fo¨r-
ster, S. Luschnig, and M.M.M., unpublished) and will be described in detail later. The Smg5 alleles
are balanced over CyO, P{Dfd:eYFP w+} (Le et al., 2006). Other alleles used were P{w[+mC]=EPg}
HP20647 (Staudt et al., 2005), Mekk1Ur36 (Inoue et al., 2001) recombined on FRT82B by D. Ryoo,
ey-FLP (Newsome et al., 2000), pcm14 (Waldron et al., 2015), Adhn4 (Chia et al., 1987) and
DHR783 (Fisk and Thummel, 1998). Control chromosomes were y w FRT19A (for Upf1 and Upf2) and
FRT82B (for Mekk1) (Xu and Rubin, 1993). For all experiments using Gadd45F17 we used the
Gadd45E8 precise excision as a control.
For viability assays, we mated flies for 3 days and collected all progeny each day for 10 days,
starting 10 days after the cross was initiated. The total numbers of F1 mutant and balancer males
were scored, and the ratio of mutant males to balancer males was used to determine mutant animal
viability. To control for balancer viability within each experiment, we normalized the ratio of mutant
to balancer animals to a ratio of the appropriate control chromosome to balancer animals produced
from a parallel cross.
Deficiency suppressor screen
We screened autosomal deficiencies from the DrosDel collection (Ryder et al., 2007). All deficien-
cies scored can be found in Supplementary file 1. Deficiencies on chromosome 2 were balanced
over CyO, and deficiencies on chromosome 3 were balanced over TM6C. We mated males from
each deficiency stock to y w Upf225G FRT19A/FM7i, P{ActGFP}JMR3 females and scored all F1 males
for the presence or absence of each balancer. For any given deficiency tested, the percentage of
Deficiency / + males that are Upf225G mutants, less the percentage of Balancer / + males that are
Upf225G mutants was calculated, producing a Deficiency Suppression Score (DSS), which represents
the effect of an individual deficiency on the increase or decrease in Upf225G viability, while control-
ling for each deficiency’s general influence on viability. A DSS greater than 0.1 indicates suppression
of lethality. Supplemental deficiencies used were from the Exelixis collection (Parks et al., 2004) and
Df(2R)sple-J1 (Heitzler et al., 1993). Deficiency mapping to the Drosophila genome was performed
using the 5.1 genome release.
RNA-seq data sets were acquired from Chapin et al. (2014) (archives SRR896609, SRR896616,
SRR503415, and SRR503416) and aligned using Bowtie and TopHat alignment with standard
Nelson et al. eLife 2016;5:e12876. DOI: 10.7554/eLife.12876 7 of 13
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remapping parameters to the 5.1 Drosophila genome release. SAMtools accessory scripts were used
to retrieve read counts for deficiency and control regions. All read counts were normalized to reads
per million within each data set. Average normalized reads in Upf225G samples were normalized to
the relative reads of 74 ribosomal proteins in Upf225G samples compared to control samples. Total
normalized reads within the regions removed by each deficiency were averaged between biological
replicates, and the difference between the Upf225Gand control samples was divided by one million
to determine percent increase in genomic load across each deficiency region.
Generation of Gadd45 mutants
We produced P-element excision lines from the P{w[+mC]=EPg}HP20647 P-element insertion line
crossed to a D2–3 transposase stock. We mated F1 males containing the P-element and transposase
on a CyO balancer to w; Tft / CyO females. Cy+ Tft white-eyed F2 males were then individually
mated to w; Tft / CyO females. We then collected Tft+, Cy males and females to create an isogenic
stock from each individually mated F2 male. To identify precise excisions we used the primers
Gadd45_F1 / Gadd45_R1 flanking the P-element insert site to amplify a region across the excised P-
element. Lines that failed to amplify with these primers were candidate imprecise excisions, which
we then tested with Gadd45_F1 / Gadd45_R3 primers for deletions. Any detected deletions were
subsequently sequenced using these same primers. Primer sequences are found in
Supplementary file 2.
Induction and analysis of eye clones
We generated eye clones with the FLP/FRT system using the ey-FLP driver (Newsome et al., 2000)
to induce recombination. We imaged eyes on a Leica MZ125 stereo microscope with a Retiga-2000R
camera (QImaging, Canada) with QCapture 3.1.2 software (QImaging). We focused images using
the ImageJ stack focuser plugin and quantified relative eye clone size using the ImageJ analyzer
tools. A total of 20 eyes from 20 individual animals were scored for each condition.
Cell death assays
For TUNEL assays, third instar larval wing discs were dissected as described in Sullivan et al.
(Sullivan et al., 2000). TUNEL staining was performed using the Apoptag Red in situ Apoptosis
Detection Kit (Chimicon International Inc., Billerica, MA) according to Chakraborty et al.
(Chakraborty et al., 2015). We DAPI stained wing discs (1:5000) for 5 min prior to mounting. Confo-
cal images were acquired using a Zeiss LSM710 laser scanning confocal microscope (Carl Zeiss AG,
Germany). 3-dimensional datasets were acquired with a Plan-Apochromat 20X/0.8 lens, 1.34 mm z-
step, using the Zeiss ZEN software. To measure TUNEL signal intensity z-projections images were
summed with ImageJ. Background signal was removed by using the ImageJ MaxEntropy auto-
threshold. Relative total TUNEL signal intensity was calculated using the ImageJ analyzer tools to
measure the total pixel intensity within the wing discs of TUNEL images and normalized to the aver-
age intensity in control conditions.
For annexin V staining, we collected media (including floating cells) from siRNA treated cells. We
spun down media at 950g for 4 min to pellet cells, and then aspirated remaining media. Concur-
rently, we trypsinized siRNA-treated cells still on plates and added them to the same respective
tube as previously spun-down media. Following the Alexa Fluor 488 Annexin V/Dead Cell Apoptosis
Kit (Abcam, UK) protocol, we stained for apoptotic cells. We visualized cells on an Olympus IX51
microscope (Olympus, Japan) with 20X objective. We collected bright field as well as fluorescent
images using a FITC filter with a QImaging QICam Fast1394 camera and QCaptureP
software (QImaging). We analyzed cells by counting all cells within a bright field image as well as the
annexin V positive cells from the same image. The number of annexin V positive cells was divided by
total cell number to generate the fraction of apoptotic cells for each treatment. >3000 total cells
were counted across three biological replicates for each treatment.
Cell culture experiments
We cultured mouse NIH-3T3 cells (ATCC) or HEK293 cells (ATCC) in DMEM (Thermo-
Fisher, Waltham, MA) supplemented with 10% fetal bovine serum and glutamine. For siRNA experi-
ments, we transfected cells using RNAiMax and 24 pmol of negative control siRNA
Nelson et al. eLife 2016;5:e12876. DOI: 10.7554/eLife.12876 8 of 13
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(Qiagen, Netherlands), Upf1 siRNA (Qiagen), or Gadd45b siRNA (Sigma-Aldrich) for 3T3 cell experi-
ments, or negative control siRNA (Qiagen), UPF1 siRNA (Qiagen), or GADD45A siRNA (Sigma-
Aldrich, St. Louis, MO) for HEK293 experiments. For double siRNA-treated cells, we used 24 pmol
of each Upf1 and Gadd45b siRNA for 3T3 experiments or UPF1 and GADD45A siRNA for HEK293
experiments.
For actinomycin experiments, we incubated cells with siRNA for 48 hr before changing the media
and then incubated with 2 mg/mL actinomycin (Sigma-Aldrich) for 1 or 2 hr. mRNA half-life was
determined by fitting an exponential decay curve to the relative expression at each time point
(Tani et al., 2012). t1/2 was calculated based on the average expression at each time point, and the
mean t1/2 for each condition is represented.
For cell counting experiments, we trypsinized cells, incubated a small aliquot with Trypan Blue at
a final concentration of 0.04% in complete media, and counted Trypan Blue negative cells. RNA was
collected from the remaining cells, and relative mRNA levels were measured as described below.
RNA isolation and quantitative RT-PCR
For Drosophila qRT-PCR analyses, we collected 5–10 adult animals frozen in liquid nitrogen. We iso-
lated total RNA using TRIzol reagent (Invitrogen) and phase-lock tubes (5-Prime), and the RNeasy
mini kit (Qiagen). We used on-column RNase-free DNase treatment (Qiagen) to reduce genomic
contamination. We determined RNA concentration by spectrophotometer and normalized concen-
tration for reverse transcription. For reverse transcription, we used random decamers and MMLV8
reverse transcriptase (Retroscript Kit, Thermo-FIsher). We performed qRT-PCR analysis using the
SYBR Green qPCR Supermix (Bio-Rad, Hercules, CA) and the Bio-Rad iCycler thermocycler. All
experimental reactions were performed using three technical replicates and a minimum of three bio-
logical replicates per condition, and the expression level of all experimental assays was normalized
to RpL32 mRNA expression.
For cell culture qRT-PCR analyses, we collected RNA following the Zymo Research Quick RNA
MiniPrep kits protocol, and synthesized cDNA using MMLV reverse transcriptase (NEB, Ipswich, MA)
with a template of 1 mg of total RNA and priming with a T18 oligo. We measured relative mRNA lev-
els by qRT-PCR using the Masterplex ep realplex (Eppendorf, Germany) with SYBR green fluorescent
dye. Each sample was measured with technical triplicates and three biological replicates, and target
mRNA levels were normalized to those of ribosomal protein 19 (Rpl19) mRNA.
For all qRT-PCR analyses we also measured samples that had been made without reverse tran-
scriptase to ensure that signal was not due to genomic DNA. Primer sequences can be found in
Supplementary file 2.
3’ UTR cloning and sensitivity assay
We cloned the UAS-GFP::Gadd45 3’ UTR and control UAS-GFP::Act5C 3’ UTR constructs using the
primers G45_3U_X1_F / G45_3U_S1_R or Act5C_X1_F / Act5C_S1_R (Supplementary file 2) to
amplify the Gadd45 and Act5C 3’ UTRs, respectively, from genomic DNA. PCR fragments were
inserted into the Zero Blunt TOPO vector (Thermo-Fisher), sequenced to assure fidelity, and
digested and cloned into a pUAST-attB GFP vector using standard cloning procedures to replace
the SV40 3’ UTR. Plasmids were injected by BestGene (Chino Hills, CA) into a stock containing the
VK00027 attP site (Venken et al., 2006) for phiC31 directed integration. We used previously
described UAS-GFP::SV40 3’ UTR animals (Metzstein and Krasnow, 2006). For imaging, wandering
late L3 larvae were collected and examined using a Leica MZ 16F microscope and the Leica DFC340
FX camera with the Leica Application Suite v3.3.0 software.
Analysis of dHR783 and Adhn4 PTC allele stability
We collected adult F1 Upf2+; Gadd45E8/+, Upf225G; Gadd45E8/+, and Upf225G; Gadd45F17/+males
that were also heterozygous for either the dHR783 or Adhn4. The Adhn4allele is a PTC-containing
allele and has been demonstrated to be a direct NMD target based on cleavage by Smg6
(Gatfield and Izaurralde, 2004). The dHR783 allele is also a PTC-containing allele and thus is pre-
sumably degraded by NMD (Fisk and Thummel, 1998). At least three biological replicates were col-
lected for each condition. We isolated RNA and generated cDNA as described in methods above
and used this cDNA as a template for PCR amplification of the dHR78 transcript with the DRH78_F3
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/ DHR78_R3 primers and the Adh transcript with the Adh_F and Adh_R primers (Supplementary file
2), which flank the nonsense mutation in the respective transcripts. To compare the relative abun-
dance of the dHR783 allele to the wild-type allele, PCR products were Sanger sequenced, and the
relative peak intensity for a T (dHR783 allele) compared to a C (wild-type allele) at nucleotide 1063
was compared. To compare the relative abundance of the Adhn4 allele to the wild-type allele, PCR
products were digested with PvuII (a site disrupted by the n4 mutation), separated on a 1% agarose
gel and stained with ethidium bromide. The relative intensity of the cut and uncut bands was deter-
mined using ImageJ and normalized for fragment length. All samples were ran on the same gel and
compared under identical conditions. All ratios were normalized to the ratio in the Upf225G;
Gadd45E8/+condition.
Statistical analysis
All figures displaying viability assays represent a proportion of animals of the indicated genotypes
that survive to adulthood; error bars for these figures represent the 95% confidence interval of the
binomial distribution, and the Test of qual or Given Proportions was used to determine significance
difference in these proportions between genotypes. All other figures represent the mean value of
multiple replicates have error bars depicting ± 2 SEM, which is a close approximation of the 95%
confidence interval (Krzywinski and Altman, 2013). For tests between two variable measures, a
two-sided paired Student’s t-test was used to determine significance difference between mean value
data. For most qPCR experiments, data was compared to a normalized control, set to a constant of
1, so these tests were performed with a one-sided Student’s t-test.
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Figure 1—figure supplement 1. Reduced expression of specific loci, not overall mRNA abundance, produces NMD mutant suppression by
deficiencies. (A) Map of 376 autosomal DrosDel deficiencies with an isogenic background and molecularly defined breakpoints (Ryder et al., 2007) and
eight other deficiencies used to further test candidate suppressing regions without overlapping DrosDel deficiencies. 39 total deficiencies suppress
Upf225G lethality, shown in green. Regions deleted by any non-suppressing deficiencies were eliminated as candidate suppressing regions, removing
false positives and reducing the size of the candidate intervals. The three candidate suppressing regions that are deleted only by suppressing
deficiencies are indicated in black and labeled 1–3. (B) Each deficiency’s Deficiency Suppression Score (DSS) compared to percent increase in RNA
abundance in Upf225G compared to wild-type from loci removed by that deficiency according to RNA-seq from Chapin et al. (2014). Trend line in red;
statistics calculated using Pearson correlation test.
DOI: 10.7554/eLife.12876.004
Nelson et al. eLife 2016;5:e12876. DOI: 10.7554/eLife.12876 3 of 10
Short Report Cell biology
! 55!
Figure 1—figure supplement 2. Drosophila Gadd45 is an endogenous direct NMD target. (A) Gadd45 mRNA expression in adults of the given
genotypes measured by qRT-PCR. Gadd45 mRNA expression is increased 16.7-fold in Upf225G mutants, and is eliminated by Gadd45F17 mutants. p-
values display one-sided Student’s t-test of indicated condition compared to control. Error bars represent 2 SEM. (B) Fluorescence of GFP transgenes
with SV40, Act5C, or Gadd45 3’ UTRs expressed by UAS driven by Actin:GAL4 in Upf2+ or Upf225G third instar larvae. SV40 and Gadd45 3’ UTR
constructs show significantly increased fluorescence in Upf225G animals compared to Upf2+, indicating NMD-dependent post-transcriptional
degradation of mRNAs containing these UTRs. The Act5C 3’ UTR construct has similar fluorescence in both backgrounds, indicating NMD does not
regulate the post-transcriptional stability of this UTR. Micrographs show dorsal views with anterior at top. (C) MAL-A2, traL, and Gadd45 5’ and 3’
fragment mRNA expression measured by qRT-PCR in pcm14 null mutants (Waldron et al., 2015) normalized to controls. Transcript structures of a non-
NMD-target, maltase A2 (MAL-A2); a known NMD-targeted transcript, the non-sex specific isoform of transformer (traL) (Rehwinkel, 2005;
Metzstein and Krasnow, 2006); and the Gadd45 transcript (note Gadd45 has no introns). Open boxes indicate UTRs; grey boxes indicate coding
regions. NMD targeting initiates endonucleolytic cleavage near the stop codon (Gatfield and Izaurralde, 2004), producing 5’ and 3’ fragments with
unprotected ends, which are then subjected to degradation by cytoplasmic 3’-to-5’ and 5’-to-3’ exonucleases, respectively. qRT-PCR primer pairs 5’
(red) and 3’ (blue) to the cleavage site can be used to differentially measure the quantity of these fragments. The Drosophila 5’-to-3’ exonuclease is
encoded by the XRN1 homologue pacman (pcm), and fragments 3’ to an endonucleolytic NMD cleavage accumulate in Drosophila cells with reduced
XRN1 activity (Gatfield and Izaurralde, 2004). The MAL-A2 3’ primers show no difference in relative expression in pcm14 mutants compared to the 5’
primers, while tra and Gadd45 have relatively increased levels of a 3’ fragment in pcm14 mutants, revealing endonucleolytic cleavage has occurred
between the primer pairs, probably near the stop codon, indicative of NMD-initiated degradation. p-value between indicated samples using a two-
sided Student’s t-test are displayed. ns indicates a p-value greater than 0.05. Error bars represent 2 SEM.
DOI: 10.7554/eLife.12876.005
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Figure 1—figure supplement 3. F17 is a null allele of Gadd45. (A) Gadd45F17 is an imprecise excision of the P-
element P{EPg}HP20647, deleting a 894 bp region that includes the entire Gadd45 coding region. Gadd45E8 is a
precise excision of the same P-element, leaving Gadd45 intact. Coding region in grey; untranslated regions in
white. Arrowhead indicates direction of transcription. (B) Adult viability of control and Gadd45F17mutants. p =
0.4463 between Gadd45F17 and controls, using the test of equal or given proportions. Error bars represent 95%
confidence interval of the binomial distribution. n equals total number of animals scored in each cross.
DOI: 10.7554/eLife.12876.006
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Figure 1—figure supplement 4. Loss of Gadd45 does not restore NMD activity in NMD mutants. (A) Expression
of the endogenous NMD target transcript traL (Rehwinkel, 2005; Metzstein and Krasnow, 2006) in control
male, Upf225G/Y, and Upf225G/Y; Gadd45F17animals, measured by qRT-PCR. There is no significant difference in
traL expression between Upf225G/Y and Upf225G/Y; Gadd45F17animals. p-values determined by one-sided
Student’s t-test between indicated conditions are displayed. ns indicates a p-value greater than 0.05. (B) Relative
abundance of PTC-containing Adhn4 (Chia et al., 1987) and dHR783 (Fisk and Thummel, 1998) allele mRNAs
compared to wild-type allele mRNA abundance in animals heterozygous for Adhn4or dHR783in each indicated
genotype (stabilization of dHR783 was not determined in Upf225G/Y; Gadd45F17 animals). Neither reduction nor
elimination of Gadd45 restored destabilization of these alleles. p-values determined by two-sided Student’s t-test
between indicated conditions are displayed. ns indicates a p-value greater than 0.05. Error represents 2 SEM.
DOI: 10.7554/eLife.12876.007
Nelson et al. eLife 2016;5:e12876. DOI: 10.7554/eLife.12876 6 of 10
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Figure 2—figure supplement 1. Loss of Gadd45 suppresses ectopic cell death in Smg5 mutant wing discs. (A to
D) DAPI (blue) and (A’ to D’) TUNEL (red) staining in late 3rd instar larval wing discs from Smg5G115/+ (A);
Smg5G115/C391 (B); Smg5G115/+ Gadd45F17 (C); and Smg5G115/C391 Gadd45F17 (D) animals. Smg5G115 and Smg5C391
are null Smg5 alleles (J.O.N. and M.M.M., unpublished). Scale bar represents 100 mm. (E) Relative TUNEL signal in
wing discs, normalized to Smg5G115/+. p-values determined by two-sided Student’s t-test between indicated
conditions are displayed. ns indicates a p-value greater than 0.05. Error bars represent 2 SEM.
DOI: 10.7554/eLife.12876.009
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Figure 3—figure supplement 1. GADD45A mediates cell lethality in Upf1 knockdown HEK293 cells. (A) Relative GADD45A mRNA expression
measured by qRT-PCR in UPF1 and GADD45A single and double siRNA knockdown 72 hr after siRNA transfection in HEK293 cells, normalized to
expression in the control siRNA condition. p-values display one-sided Student’s t-test for each condition compared to control. (B) Viable cell count of
UPF1 and GADD45A single and double siRNA-treated cells normalized to control siRNA -treated cells. p-values display two-sided Student’s t-test
between indicated conditions. (C) Relative UPF1 mRNA expression measured by qRT-PCR in UPF1 and GADD45A single and double siRNA knockdown,
normalized to expression in control siRNA condition. p-values display one-sided Student’s t-test for each condition compared to control. Error bars
represent 2 SEM.
DOI: 10.7554/eLife.12876.011
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CHAPTER 3 
 
SMG5 IS REQUIRED FOR MULTIPLE NONSENSE- 




 Maintaining error-free translation is important to preserve the fidelity of protein 
function. Eukaryotic cells utilize a number of mRNA surveillance mechanisms to 
prevent the translation of erroneous proteins (Adjibade and Mazroui, 2014). One of these 
mechanisms, the nonsense-mediated mRNA decay (NMD) pathway, selectively destroys 
mRNAs that contain premature termination codons (PTCs) in the open reading frame, 
preventing their translation (Celik et al., 2015). NMD also degrades many endogenous 
wild-type mRNAs, acting as a mechanism of post-transcriptional gene regulation 
(Peccarelli and Kebaara, 2014). NMD is critical for viability in most complex organisms 
(Arciga-Reyes et al., 2006; Avery et al., 2011; Frizzell et al., 2012; Medghalchi et al., 
2001; Metzstein and Krasnow, 2006; Thoren et al., 2010; Weischenfeldt et al., 2008; 
Wittkopp et al., 2009; Yoine et al., 2006), highlighting the importance of this pathway 
for cellular function. While the phenomenon of NMD has been well characterized for 
several decades, the factors required for the activity of this pathway and the mechanisms 
of target recognition and degradation are still not well understood.  
The factors that function in the NMD pathway were first identified in screens in
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yeast and C. elegans (Cali et al., 1999; Hodgkin et al., 1989; Leeds et al., 1991; 1992). 
These screens discovered seven proteins that are required for NMD function in most 
eukaryotes: Upf1, Upf2, and Upf3, which were found in every eukaryote examined, and 
Smg1, Smg5, Smg6, and Smg7, which are variable in their presence in different species 
(Siwaszek et al., 2014). After these genes were first identified, a series of genetic 
analyses in yeast and C. elegans mutants lacking NMD genes provided the foundation to 
build a model of the NMD mechanism. Double and triple mutants between the NMD 
genes UPF1, UPF2, and UPF3 in S. cerevisiae were found to all have similar defects to 
each individual mutant, indicating that all three of these genes are equally required for 
NMD and probably function together in this process (Atkin et al., 1997). Additionally, 
double mutant combinations of smg-1 through smg-6 in C. elegans also revealed that 
there is no synergistic effect on PTC-containing mRNA stabilization (Hodgkin et al., 
1989). These findings indicated that all known NMD factors are equivalently required 
for all NMD activity, providing context to interpret the characterization of the molecular 
interactions between these factors, suggesting that they function together in a complex 
(Weng et al., 1996; Yamashita et al., 2001). C. elegans double mutants also revealed that 
smg-1, smg-3 (Upf2), and smg-4 (Upf3) are required for phosphorylation of SMG-2 
(UPF1), but smg-5, smg-6, and smg-7 are required to prevent SMG-2 hyper-
phosphorylation (Page et al., 1999), suggesting that regulation of Upf1 phosphorylation 
may be a critical step in the NMD process. This discovery linking Upf1 phosphorylation 
to NMD function informed how the biochemical interactions of Smg5, Smg6, and Smg7 
binding to phosphorylated residues on Upf1 may contribute to NMD activity (Chiu et al., 
2003; Ohnishi et al., 2003; Okada-Katsuhata et al., 2012). Combining an understanding 
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of the molecular interactions of the NMD factors with genetic analysis of the 
requirements of these genes for NMD function has shaped the model of the NMD 
mechanism. 
Even though genetic analysis has provided critical context for interpreting the 
molecular interactions of NMD factors, there has been very little characterization of the 
individual contribution of NMD genes in vivo in organisms other than yeast and C. 
elegans. The lack of genetic analysis in these organisms may be due to the fact that 
reduced expression of any NMD gene causes lethality in plants, zebrafish, mice, and 
human cells (Arciga-Reyes et al., 2006; Kerényi et al., 2008; Li et al., 2015; Medghalchi 
et al., 2001; Thoren et al., 2010; Weischenfeldt et al., 2008; Wittkopp et al., 2009; Yoine 
et al., 2006), indicating NMD is an essential feature of biology in these more complex 
organisms. Additionally, inhibition of any individual NMD factor in Drosophila cells 
produces a similar genomic profile of gene expression changes due to stabilization of 
endogenous and PTC-containing NMD targets (Rehwinkel et al., 2005). The similar 
phenotypes between the reduced activity of individual NMD factors in these systems is 
consistent with the idea that all NMD genes are equivalently required for any NMD 
function, as observed in yeast and C. elegans. However, most of these studies were done 
using RNA interference to reduce expression of genes required for NMD, and not with 
genetic ablation of gene activity. It is possible that the similar phenotypes are the result 
of incomplete and variable expression knockdown, masking the true phenotype that may 
occur upon complete loss of each individual NMD factor. Mutations in A. thaliana upf1, 
upf3, and smg7 cause early developmental lethality (Hori and Watanabe, 2005; Riehs et 
al., 2008; Yoine et al., 2006), and mouse mutants lacking Upf1, Upf2, Smg1, or Smg6 all 
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die during early embryonic development (Li et al., 2015; McIlwain et al., 2010; 
Medghalchi et al., 2001; Weischenfeldt et al., 2008), consistent with each gene being 
similarly required for NMD function. However, these mutants may have subtle 
differences in the efficiency of NMD activity, which has been difficult to determine due 
to this very early lethality, and the potential combinatorial effects of these mutations are 
yet to be tested in either organism. The lack of genetic tools to test the requirement of 
each NMD factor has limited the ability to characterize the individual contribution of 
each gene in a native setting.  
 Drosophila melanogaster mutants are the only other genetic models of loss of 
NMD in an organism where it is required for viability; however, Drosophila is the 
exception to the trend that loss of any NMD factor has similar effects on viability. 
Drosophila with null mutations in Upf1 or Upf2 die during early larval stages, and these 
animals never survive to adulthood (Chapin et al., 2014; Metzstein and Krasnow, 2006). 
However, Drosophila with mutations in Upf3, Smg1, and Smg6 can survive to adulthood 
(Avery et al., 2011; Chen et al., 2005; Frizzell et al., 2012; Metzstein and Krasnow, 
2006). It has been suggested that this difference in requirement for these NMD factors is 
due to non-NMD functions of Upf1 and Upf2 being required for viability, and not 
differences in NMD activity (Avery et al., 2011). However, we have recently shown that 
Upf1 and Upf2 mutants can survive to adulthood by eliminating the expression of a 
single endogenous NMD target (Nelson et al., 2016), indicating that the lethality of Upf1 
and Upf2 mutants is in fact likely due to the specific loss of NMD activity. This finding 
further suggests that the differences in viability between Upf1 and Upf2 mutants and 
Upf3, Smg1, and Smg6 mutants is likely due to differences in their requirement for the 
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NMD process. In particular, the viability of Upf3, Smg1, and Smg6 mutants suggests that 
these animals have sufficient NMD activity to survive to adulthood. This possibility 
would imply that in the absence of one of these factors a redundant mechanism can be 
used to recognize and degrade NMD targets in Drosophila. It is possible that these three 
genes function in three independent NMD mechanisms, allowing for residual NMD 
activity to occur when any one of these genes are lost.  
Smg5 is the only known NMD gene for which loss-of-function mutations are yet 
to be characterized in Drosophila or any other species that require NMD for viability. 
Smg5 is perhaps the least well understood NMD factor, and it is possible that it may 
account for some of the residual NMD activity in viable Drosophila NMD mutants. Here 
we describe the first analysis of Drosophila Smg5 mutants and discover that Smg5 is a 
critical NMD gene required for viability. To understand how Smg5 is required for NMD, 
we performed the first double-mutant analysis of NMD genes in Drosophila. Our 
findings suggest Drosophila utilize multiple independent mechanisms to initiate NMD 





 Drosophila melanogaster stocks were raised on standard cornmeal/dextrose food 
at 25°. The NMD mutant allele Smg132AP (Metzstein and Krasnow, 2006) is on a y w 
FRT19A chromosome and Smg6292 (Frizzell et al., 2012) is on an FRT82B chromosome and 
balanced over TM6B, P{Dfd-EYFP} Sb1 ca1 (Le et al., 2006). All Smg5 alleles are on 
FRT40A chromosomes. Other alleles used were Gadd45F17 (Nelson et al., 2016), pcm14 
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(Waldron et al., 2015) and DHR783 (Fisk and Thummel, 1998). y w FRT19A was used as 
a control chromosome for all experiments. 
For the genetic screen, FRT40A males were starved for 8 hours, and then fed on 
sucrose with 1% ethyl methanesulfonate over night to induce mutagenesis. Mutagenized 
males were then mated with FRT40A; P{Da-GAL4 w+} P{UAS-FLP} P{UAS-
eGFP::SV40 3’UTR} females, and F1 late wandering L3 larvae were collected in 
glycerol and scored for mosaic enhanced GFP fluorescence using a Leica MZ 16F 
microscope. Mosaic animals were cleaned in PBS and placed in vials with food to 
continue development. After eclosion, candidate mutant lines were established and 
retested to confirm an NMD defect. Candidate alleles were tested for complementation 
with Df(2L)BSC345, which deletes the Smg5 locus, and lines that failed to complement 
this deficiency were sequenced at the Smg5 locus. Isolated Smg5 alleles are balanced 
over CyO, P{Dfd:eYFP w+} (Le et al., 2006).  
For viability tests, animals containing mutant alleles over a balancer were mated 
for three days, and offspring were collected for 10 days, beginning 10 days after mating 
began. All balancer- and balancer+ animals were scored, and percent expected viable was 
determined by the ratio of balancer- animals to balancer+ animals.   
 
RNA isolation and quantification 
For qRT-PCR analyses, we collected five to ten 0-4 h L3 larvae and froze them 
in liquid nitrogen. We isolated total RNA using TRIzol reagent (Invitrogen) and phase-
lock tubes (5-Prime), and the RNeasy mini kit (QIAGEN). We used on-column RNase-
free DNase treatment (QIAGEN) to reduce genomic contamination. We determined 
RNA concentration by spectrophotometer and normalized concentration for reverse 
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transcription. For reverse transcription, we used random decamers and MMLV8 reverse 
transcriptase (Retroscript Kit, Ambion). We performed qRT-PCR analysis using the 
SYBR Green qPCR Supermix (Bio-Rad) and the Bio-Rad iCycler thermocycler. All 
experimental reactions were performed using three technical replicates and a minimum 
of three biological replicates per condition, and the expression level of all experimental 
assays was normalized to RpL32 mRNA expression. For all qRT-PCR analyses, we also 
measured samples that had been made without reverse transcriptase to ensure that signal 
was not due to genomic DNA.  
Primer sequences used were RpL32_1 (ATGCTAAGCTGTCGCACAAA), 
RpL32_2 (CGATGTTGGGGCATCAGATAC), Gadd45_5’_1 
(CATCAACGTGCTCTCCAAGTC), Gadd45_5’_2 
(CGTAGATGTCGTTCTCGTAGC), Gadd45_3’_1 
(ACAGCCAGATGTCACAGAATT), and Gadd45_3’_2 
(CCAGCAACTGGTTTCCATTAG). All Gadd45 qPCR analysis was done using the 
Gadd45_5’ primer pair unless otherwise noted. 
 
Analysis of dHR783 PTC allele stability 
We collected adult Smg5+/G115 or Smg5C391/G115 males that were also heterozygous 
for the dHR783 allele. The dHR783 allele is a PTC-containing allele that has lower 
expression than the wild-type allele, and thus is presumably degraded by NMD (Fisk and 
Thummel, 1998). At least three biological replicates were collected for each condition. 
We isolated RNA and generated cDNA, as described above, and used this cDNA as a 
template for PCR amplification of the dHR78 transcript with the DRH78_F3 / 
DHR78_R3 primers (TGGGGCTTATTCAGAGTTCG / 
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ATTAATGCTGGCCACACTCC), which flank the nonsense mutation. To compare the 
relative abundance of the dHR783 allele to the wild-type allele, PCR products were 
Sanger sequenced, and the relative peak intensity for a thymine (dHR783 allele) 
compared to a cytosine (wild-type allele) at nucleotide 1063 was compared. 
 
Lethal phase and larval development analysis 
 For lethal phase and larval development analysis, first-instar larvae were 
collected 20-24 hours after egg lay. Animals were examined every 24 hours, their 
developmental stage was recorded, and they were transferred to fresh food. Larval stage 
was determined based on physical characteristics of the mouth hooks. Once animals 
entered pupariation, pupae were transferred to vials and scored for eclosion to adulthood 
five days later. 
 
Results 
Drosophila Smg5 is an essential NMD factor 
 To identify novel Drosophila Smg5 mutant alleles, we performed an EMS 
mutagenesis screen in animals expressing an NMD-sensitive GFP reporter. This reporter 
expresses the GFP coding sequence from a UAS promoter and has the SV40 3’UTR 
(Metzstein and Krasnow, 2006). The SV40 3’ UTR is targeted by NMD, so cells with 
defective NMD activity have increased reporter expression and GFP fluorescence 
(Metzstein and Krasnow, 2006). Since mutations in Smg5 are potentially lethal, like 
Upf1 and Upf2 mutations, we screened genetic mosaic animals for loss of NMD activity 
in individual cells. To do so, we used the da-GAL4 driver to ubiquitously express the 
NMD sensitive GFP::SV40 3’ UTR reporter and FLP recombinase from UAS promoters 
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in Drosophila larvae. FLP-mediated recombination of FRT sites located near a 
centromere produces daughter cells homozygous for the chromosome arm with the FRT 
sequence. If the recombined chromosome arms are heterozygous for a mutation in a gene 
required for NMD, then cells that become homozygous for that mutation after FRT 
recombination will show increased reporter GFP fluorescence compared to other cells 
(Figure 3.1A). We observed that mosaic loss of NMD activity causes late L3 larvae to 
show multiple patches of brighter GFP fluorescence, but non-mosaic animals express a 
uniform fluorescent signal across the entire animal (Figure 3.1B). The mosaic enhanced 
fluorescence phenotype is easy to distinguish, and mosaic animals remain viable and 
fertile, so lines can be established from individual identified mutants. An added benefit 
of this approach is that mutagenizing animals that have an FRT site located near the 
centromere on the left arm of the second chromosome (FRT40A) will isolate mutations 
only on this chromosome arm. Since Smg5 is the only known NMD gene located on the 
left arm of the second chromosome, mutations identified from the screen will be 
enriched for alleles of Smg5.  
Using this approach, we screened 12,554 larvae and identified three mutants with 
mosaic GFP fluorescence enhancement. These three mutants, A1, EI1, and MI1, were all 
homozygous lethal. To test if these alleles had mutations in Smg5, we crossed each allele 
to a deficiency that deletes Smg5. We found that all three of these alleles were lethal over 
this deficiency (Figure 3.2A), indicating that they had mutations in Smg5. Sequencing of 
the Smg5 locus identified that each allele had a nonsense mutation in the Smg5 coding 
sequence (Figure 3.2B), suggesting they are loss-of-function alleles. In a parallel screen 
that expressed the GFP::SV40 3’ UTR reporter in the larval tracheal system (Förster et 
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al., 2010), we also identified four mutants that had increased GFP fluorescence  (Figure 
S3.1A-E). These mutations were mapped to the second chromosome, indicating they 
may be alleles of either Smg5 or Upf3, the only known NMD genes located on that 
chromosome. These alleles were also homozygous lethal, so they were crossed to the 
deficiency that deletes Smg5 and tested for viability. Two of these alleles, G115 and 
C391, were lethal over this deficiency (Figure 3.2A), and sequencing of the Smg5 locus 
revealed they respectively had a nonsense mutation and an altered splice acceptor site in 
Smg5 (Figure 3.2B). The nature of these mutations suggested that they were also loss-
of-function alleles, and when the viability of these alleles was tested as trans-
heterozygotes, they were also found to be lethal (Figure 3.1B), confirming that they are 
null mutations. The other two alleles, Q454 and Q376, were viable over the deficiency 
that deletes Smg5 (Figure 3.2A), but they also had increased fluorescence of the 
GFP::SV40 3’ UTR reporter when over this deficiency (Data not shown). These results 
suggested they may have been viable hypomorphic alleles of Smg5 with linked lethal 
mutations. We sequenced Smg5 in these mutants, and discovered they both had missense 
mutations in highly conserved alpha-helices of the Smg5 14-3-3-like domain (Figure 
3.2B) (Fukuhara et al., 2005). All together we isolated seven total Smg5 mutants from 
these two screen – five likely null alleles and two hypomorphic alleles. Importantly, the 
near complete lethality of these Smg5 loss-of-function mutants indicates that Smg5 is 
required for viability. 
Lethal Drosophila NMD mutations generally have more severe defects in NMD 
function than viable mutations, as measured by increased expression of endogenous 
NMD targets (Frizzell et al., 2012; Metzstein and Krasnow, 2006). To test if lethal Smg5 
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mutant alleles also have strong defects in NMD activity, we used qRT-PCR to measure 
the expression of the endogenous NMD target Gadd45 (Chapin et al., 2014; Nelson et 
al., 2016). Since Gadd45 is directly targeted by NMD, the amount of increased Gadd45 
expression in Smg5 mutants compared to controls serves as an indirect measure of the 
decrease in NMD activity. We measured Gadd45 expression in early third instar larvae 
and found that Smg5C391/G115 mutants had a strong increase in Gadd45 mRNA, while 
Smg5Q454/G115 hypomorphs had a weaker expression increase (Figure 3.2C). These 
findings are consistent with the previously observed trend that lethal mutations in NMD 
genes have more severe defects in NMD activity than viable mutations (Frizzell et al., 
2012). Smg5C391/G115 mutants also fully stabilized the expression of PTC containing 
mRNAs (Figure 3.2D), indicating that this defect in NMD function is not restricted to 
the degradation of endogenous NMD targets, but that Smg5 mutants essentially have a 
complete loss of NMD activity.  
Upf1 and Upf2 null mutants have delayed development and die during larval 
stages (Chapin et al., 2014). We found that Smg5C391/G115 mutants also have 
developmental delays, with Smg5 mutants spending almost twice as long in larval stages 
as control animals (Figure S3.2B), and most Smg5C391/G115 mutants die during 
pupariation (Figure S3.2A). This developmental delay and lethal phase is similar to, but 
somewhat weaker than, the defects in Upf1 and Upf2 mutants (Chapin et al., 2014). This 
difference in the timing of lethality in Upf1 and Upf2 mutants compared to Smg5 
mutants suggests that these animals may be dying due to different causes, even if all 
three conditions lack NMD function. Increased Gadd45 expression is a major factor 
contributing to the death of Upf1 and Upf2 mutants, and loss of Gadd45 suppresses Upf1 
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and Upf2 mutant lethality (Nelson et al., 2016). Given the strong increase of Gadd45 
expression in Smg5C391/G115 mutants, it is likely that these animals are also dying due to 
excessive Gadd45. We found that loss of Gadd45 also suppresses the lethality of 
Smg5C391/G115 mutants (Figure 3.2E), indicating that these animals are dying due to a 
similar loss of NMD function as Upf1 or Upf2 mutants. These results combined strongly 
suggest that Smg5 mutant lethality is specifically due to a loss of NMD activity, and not 
due to loss of any potential NMD-independent Smg5 function. 
 
Smg5 is required for Smg6 endonuclease activity 
 Smg6 is an endonuclease that cleaves NMD-targeted mRNAs near the stop 
codon, exposing free 5’ and 3’ ends, which can then be degraded by the cells general 
exonucleases (Gatfield and Izaurralde, 2004; Huntzinger et al., 2008). Smg6-mediated 
cleavage is the only known mechanism for degradation of NMD targets in Drosophila; 
however, Smg6-independent decay must occur since Smg6 mutants are viable and have 
weak NMD defects (Frizzell et al., 2012). To test if Smg5 mutants lose Smg6 
endonuclease activity, we tested NMD target cleavage in Drosophila lacking the lone 
cytoplasmic 5’-to-3’ exonuclease Xrn1, which is encoded by the gene pacman (pcm). 
pcm14 mutants are null and no longer have functioning 5’-to-3’ exonuclease activity 
(Waldron et al., 2015), and thus mRNAs cleaved by Smg6 in this mutant show increased 
expression of the fragment 3’ to the cleavage site compared to the 5’ fragment (Nelson et 
al., 2016). This difference in the expression of the 3’ and 5’ region of NMD targets likely 
occurs in pcm14 mutants because 3’ fragments produced after Smg6 cleavage are no 
longer degraded by Xrn1, but the 5’ fragments are still degraded by the functioning 3’-
to-5’ exonuclease. We found that in pcm14; Smg6292/Df double mutants, the preferential 
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stabilization of the 3’ fragment of Gadd45 is lost (Figure 3.3A, B), indicating that the 
preferential increase in expression of the 3’ region is due to Smg6 endonuclease activity. 
Interestingly, we found that the preferential stabilization of the 3’ fragment is also lost in 
pcm14; Smg5C391/G115 double mutants (Figure 3.3A, B). These results indicate that Smg5 
is required for any Smg6 endonuclease activity to occur. 
 
Smg5 is not required for decapping and Xrn1-mediated decay 
 Although we found that Smg5 is required for NMD targets to be degraded by the 
Smg6 endonuclease, Smg5 mutants have much stronger defects than Smg6 mutants, 
indicating that Smg5 is also required for an additional Smg6-indpendent decay 
mechanism. Human Smg5 can indirectly interact with both decapping and deadenylation 
complexes (Cho et al., 2013; Loh et al., 2013); however, whether either of these 
interactions occur during native NMD conditions is unclear. Any decay mechanism that 
occurs via decapping would require 5’-to-3’ exonucleases to complete degradation of the 
mRNA, and a deadenylation mechanism would require 3’-to-5’ exonucleases. To test if 
decapping-mediated decay contributes at all to the degradation of NMD targets in 
Drosophila, we measured Gadd45 expression in pcm14 mutants and controls using the q-
PCR primer pair 5’ to the Gadd45 termination codon (Figure 3.3A). Xrn1 would only 
degrade Gadd45 mRNA in this region after decapping occurs, but not after Smg6 
endonuclease activity, as with the 3’ primer pair, so this assay allows us to determine the 
contribution of Xrn1 decay specifically after decapping of this NMD target. We found a 
small increase in Gadd45 expression in pcm14 mutants compared to controls (Figure 
3.3C), suggesting that this mRNA is subjected to a low amount of decapping and 5’-to-
3’ degradation, but we cannot yet determine if this decay occurs due to NMD activity. 
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Decapping followed by Xrn1 endonuclease activity can occur due to many 
different mechanisms that are independent from NMD function (Siwaszek et al., 2014). 
The relative expression in pcm14 mutants compared to control animals represents the 
increased stability that occurs due to loss of both Smg5-independent and any potential 
Smg5-dependent Xrn1 decay activity. To separate the two potential Xrn1 decay 
activities, we measured Gadd45 expression in pcm14; Smg5C391/G115 double mutants 
compared to Smg5C391/G115 mutants alone using the 5’ q-PCR primers. Any decay activity 
that requires both Smg5 and Xrn1 will already be lost in a Smg5 mutant, so the relative 
expression in the double mutant compared to the Smg5 mutant will represent only the 
increased stability due to loss of specifically Smg5-independent Xrn1 decay activity. If 
any Smg5-dependent Xrn1 decay activity exists, then we expect the relative Gadd45 
expression in pcm14 mutants compared to control animals to be greater than the relative 
expression in pcm14; Smg5C391/G115 double mutants compared to Smg5C391/G115 mutants. If 
no Smg5-dependent Xrn1 decay activity exists, then there should be no difference in 
relative Gadd45 expression in these two comparisons, because in both experiments, only 
Smg5-independent Xrn1 decay is being lost. We found that there was no difference in 
the relative expression between pcm14 mutants compared to control animals and pcm14; 
Smg5C391/G115 animals compared to Smg5C391/G115 mutants (Figure 3.3C, D). These 
results indicate that Xrn1 does not require Smg5 to degrade the 5’ region of Gadd45 
mRNA, suggesting that Smg5 does not promote decapping of NMD targets. However, 
these results do not mean that NMD does not induce target decapping at all in 
Drosophila, as decapping enzymes may be directly recruited by Upf1 independent from 
Smg5 function. 
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Smg1 and Smg6 function together to degrade NMD targets 
Smg6 binds Upf1 at phosphorylated residues (Fukuhara et al., 2005; Okada-
Katsuhata et al., 2012), suggesting that Smg1 kinase activity is required to first 
phosphorylate Upf1 for Smg6 to cleave NMD targets. However, Drosophila Smg6 
mutants have much stronger defects in viability and NMD activity than Smg1 mutants 
(Chen et al., 2005; Frizzell et al., 2012; Metzstein and Krasnow, 2006), and Smg6 has 
been shown to be capable of binding Upf1 in the absence of functional Smg1 in human 
cells (Chakrabarti et al., 2014; Nicholson et al., 2014). These reports suggest an 
alternative model in which Smg6 can cleave NMD targets without Smg1 kinase activity. 
The contribution of Smg1 to NMD may then be independent of Smg6 function, or it may 
act to enhance Smg6 binding to Upf1, even if Smg6 can degrade NMD targets in the 
absence of Smg1. These possibilities can be distinguished by examining the potential 
additive NMD defects of Smg1; Smg6 double mutants. If Smg1 and Smg6 function in 
independent decay mechanisms, we expect a Smg1; Smg6 double mutant would have 
enhanced defects compared to loss of Smg6 alone. Alternatively, if Smg1 only functions 
to recruit Smg6, and thus is dependent on Smg6 for all NMD activity, we expect Smg1; 
Smg6 double mutants to have no more severe defects than a Smg6 mutant. We found that 
Smg132AP; Smg6292/Df double mutants showed no difference to Smg6292/Df single mutants 
in viability, Gadd45 expression, or stage of lethality (Figure 3.4A-C). Together, these 
data indicate that Smg1 function is completely dependent on Smg6, and suggest that 
Smg1 contributes to, but is not required for, Smg6 binding to Upf1, and that Smg1 is not 




Smg1 functions in a subset of Smg5 decay activity 
 Since we found that Smg5 is required for Smg6 endonuclease activity and that 
Smg6 is required for Smg1 NMD function, it is likely that Smg1 and Smg5 function in the 
same pathway to promote Smg6 decay activity; however, it is possible that they 
independently contribute to Smg6 function. To determine if Smg1 and Smg5 are both 
required for the same decay mechanism, we tested if Smg1; Smg5 null double mutants 
have a larger increase in Gadd45 expression than Smg5 null mutants alone. We found 
that loss of Smg1 did not increase the expression of Gadd45 in Smg5 mutants (Figure 
3.5A), suggesting that Smg1 and Smg5 do function in the same pathway. We could not 
directly test if loss of Smg1 enhances Smg5 null mutant lethality because Smg5 null 
mutants are completely lethal (Figure 3.5B); however, we could test if Smg1; Smg5 null 
double mutants die earlier than Smg5 mutants. We found that loss of Smg1 neither 
enhances the developmental delay observed in Smg5 mutants, nor shifts the lethality 
from pupariation to the larval stages, when Upf1 and Upf2 mutant die (Figure S3.2A, B) 
(Chapin et al., 2014). These findings indicate that Smg1 is dispensable for NMD activity 
in Smg5 mutants, and suggests that Smg5, like Smg6, is required for all Smg1-dependent 
decay activity. 
 The more severe defects of Smg5 mutants than Smg1 mutants suggests that Smg5 
may be required for the residual NMD activity that occurs in Smg1 mutants. To test if 
Smg5 has a Smg1-independent NMD activity, we tested if Smg5 hypomorphs, which are 
normally completely viable with weak NMD defects, would enhance the defects of Smg1 
mutants. We found that when Smg1 is lost in Smg5 hypomorphs, most of these animals 
now fail to survive to adulthood (Figure 3.5C), and Smg132AP; Smg5Q454/G115 double 
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mutants have a much larger increase in Gadd45 expression than either mutation alone 
(Figure 3.5D). These results indicate that Smg5 is required for NMD activity that is 
independent of Smg1, and suggest that Smg5 is required for multiple NMD functions, 
one that also requires Smg1 and one or more that does not. 
 
Discussion 
Smg5 is essential for NMD function in Drosophila 
 The degradation of mRNAs containing premature termination codons by the 
nonsense-mediated mRNA decay (NMD) pathway is a crucial cellular quality-control 
function. While many factors required for NMD have been characterized, the individual 
contribution of each factor to the recognition and degradation of NMD targets is not 
fully understood. Most of our understanding of how these factors contribute to NMD has 
come from discerning the molecular interactions that occur between these proteins 
during the NMD process, but there is relatively little description of the defects that occur 
when individual NMD factors are genetically ablated. Through the first analysis of 
Drosophila Smg5 mutants and double mutants of NMD genes, we have found that NMD 
utilizes multiple mechanisms to promote target degradation, potentially via several 
different molecular interactions. Our data are consistent with the idea that the decay of 
NMD target mRNAs is preceded by Smg6 endonuclease activity, and this mechanism 
requires Smg5. Additionally, we show that Smg5 is required for a separate decay process 
(Figure 3.6). This discovery was surprising given that Smg5 is the least well 
characterized NMD factor, and was previously thought only to promote NMD complex 
recycling and not to be required to stimulate decay activity (Ohnishi et al., 2003). The 
finding that Smg5 mutants have as severe defects as Upf1 and Upf2 mutants indicates 
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that Smg5 is actually a critical factor for promoting decay mechanisms. 
 
Smg1 kinase activity does not contribute to the defects in Smg5 
 or Smg6 mutants 
One explanation for the strong defect in Smg5 mutants may be the loss of 
dephosphorylation of Upf1. Smg1 is a kinase that phosphorylates Upf1 at multiple 
residues (Grimson et al., 2004; Yamashita et al., 2001). This phosphorylation in turn can 
promote Smg5 and Smg6 binding (Anders et al., 2003; Ohnishi et al., 2003). Smg5 also 
binds the PP2A phosphatase, recruiting it to the NMD complex, and this recruitment is 
thought to lead to dephosphorylation after target degradation has been initiated (Anders 
et al., 2003; Ohnishi et al., 2003). In C. elegans Smg5 mutants, Upf1 (SMG-2) is found 
to be hyper-phosphorylated in a Smg1-dependent manner (Page et al., 1999). Failure to 
dephosphorylate Upf1 may be the cause of the strong NMD defect in our Drosophila 
Smg5 mutants; however, it is unclear how failure to dephosphorylate Upf1 leads to loss 
of NMD activity. Though Smg1 is thought to be necessary for Upf1 phosphorylation, 
loss of Smg1 has little effect on NMD activity in Drosophila (Chen et al., 2005; 
Metzstein and Krasnow, 2006), indicating that Upf1 phosphorylation is not a necessary 
step in the NMD process in this organism. As a corollary to these findings, Smg1 
mutants should suppress Smg5 mutant defects, since Smg5 would not longer be required 
for Upf1 dephosphorylation. However, we found just the opposite: Smg1 mutants do not 
suppress Smg5 mutants at all, and Smg1 mutants actually enhance the defect of Smg5 
hypomorphic alleles (Figure 3.5C, D). These data suggest Smg5 has functions 
independent of Smg1 in Drosophila NMD. It is possible that another PIK-related kinase 
could phosphorylate Upf1 in the absence of Smg1 in Drosophila, allowing for Smg1 
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mutants to have minor defects and also explaining why Smg1 mutants fail to suppress 
Smg5. However, given that Smg5 hypomorphic alleles maintain sufficient function for 
viability, we would expect these alleles to maintain viability in a Smg1 mutant if another 
kinase was phosphorylating Upf1. Since Smg1 has such strong synthetic defects with 
Smg5 hypomorphs, it suggests instead that these two genes have redundant functions. 
Based on these analyses of Smg1; Smg5 double mutants, we propose that these two 
NMD factors contribute to parallel decay pathways (Figure 3.7). 
 Smg5 and Smg6 contain 14-3-3-like domains, which can bind phosphorylated 
Upf1 (Fukuhara et al., 2005; Okada-Katsuhata et al., 2012), so phosphorylation of Upf1 
by Smg1 was thought to be required for Smg6 to bind Upf1 prior to cleaving target 
mRNAs. However, more recent evidence suggests that Smg6 binds Upf1 in the absence 
of Smg1 activity, through a domain separate from the 14-3-3-like domain, although it is 
unclear if this binding occurs during NMD in vivo (Chakrabarti et al., 2014; Nicholson et 
al., 2014). Interestingly, Drosophila Smg6 mutants have much stronger NMD defects 
than Smg1 mutants (Frizzell et al., 2012), consistent with the idea that Smg6 has Smg1-
independent NMD activity. Our finding that loss of Smg1 does not enhance Smg6 mutant 
defects is consistent with the idea that Smg1 functions through Smg6 activity (Figure 
3.7). This finding is the first in vivo context that reveals that Smg1 does require Smg6 
activity, but that Smg6 can function in the absence of Smg1. 
 
Smg5 is required for Smg6 endonuclease activity 
 We found that Smg5 mutants have much stronger defects in NMD activity than 
either Smg1 or Smg6 mutants, and that Smg5 mutants have completely lost endonuclease 
activity on endogenous NMD targets, indicating that Smg6 requires Smg5 function. One 
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possibility is that Smg5 is required for targeting or activation of Smg6 endonuclease 
activity, perhaps through features of the inactive PIN domain of Smg5, which has similar 
structure to the active PIN domain of Smg6 that is required for NMD activity (Glavan et 
al., 2006; Huntzinger et al., 2008). These PIN domains may be required to interact with 
one another for Smg6 endonuclease activity to occur. The contribution of individual 
Smg5 domains to NMD activity must be further investigated to dissect how Smg5 is 
required for Smg6 endonuclease activity. 
  
Smg5 is required for a Smg6-independent decay activity 
 The enhanced defects in Smg132AP; Smg5Q454/G115 double mutants and that Smg5 
mutants have more severe defects than Smg6 mutants suggests that Smg5 is required for 
Smg6-independent decay activity; however, the mechanism of this decay remains 
unclear. It is likely that Smg5 promotes decay activity through recruiting either 
decapping or deadenylation complexes to induce exonucleolytic decay. There is 
evidence that human Smg5 interacts with the Dcp decapping complex and Smg7 may 
interact with the CCR4-NOT deadenylation complex (Loh et al., 2013). Drosophila does 
not encode a direct Smg7 orthologue, but Drosophila Smg5 has some conserved regions 
with human Smg7, and it may have some of these same interactions (Chiu et al., 2003; 
Fukuhara et al., 2005). Whether either of these interactions are required during normally 
occurring NMD is not known, and so far, no genetic evidence has indicated that Smg5 is 
required for either of these alternative decay mechanisms. We found that Smg5 decay 
activity on NMD targets does not overlap with the decay activity of pcm, the lone 
Drosophila 5’-to-3’ exonuclease, which would degrade mRNAs in the event of 
decapping (Till et al., 1998). This lack of overlap between pcm and Smg5 function does 
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not mean that pcm does not contribute to NMD, as it is likely that Xrn1 (the protein 
encoded by pcm) is directly recruited by Upf1, independent of Smg5 activity, as 
previously suggested in human cells (Lejeune et al., 2003). Drosophila Smg5 may 
instead recruit deadenylation complexes, a potential function of Smg7 in human cells 
(Loh et al., 2013). The possible overlap in decay activity between the exosome, the 
predominant 3’-to-5’ exonuclease, and Smg5 will need to be tested to determine if this is 
the Smg6-independent Smg5 decay activity. 
 An alternative model for the requirement of Smg5 in NMD may be that it is 
necessary for NMD complex recycling. The Smg5 mutant defects are unlikely to be due 
to failure to dephosphorylate Upf1, because Smg1 mutants do not suppress Smg5 defects, 
and instead enhance the defects of the hypomorphic Smg5 alleles. However, it is possible 
that Smg5 is required for complex disassembly independent of Smg1 activity. Lack of 
complex recycling would explain why the Smg5 mutant defect is as severe as Upf1 and 
Upf2 mutants, and why all endonuclease and other decay activity is lost in Smg5 
mutants. While the potential role for Smg5 in complex disassembly has been postulated 
for a long time, it is yet to be directly tested (Ohnishi et al., 2003). The process of 
complex recycling itself needs to be closely investigated in Smg5 mutants to determine if 
Smg5 is required for this process, and if a defect in recycling accounts for Smg5 mutant 
NMD defects. 
  The differences in the strength of the NMD defects that occur when Smg1, 
Smg5, or Smg6 are lost suggests that there may be a biased preference for which NMD 
mechanism is used to degrade specific targets. For instance, the very weak defects of 
Smg1 mutants indicates that Smg1 actually contributes little to the decay of NMD 
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targets, suggesting that most degradation does not occur via Smg1 activity. However, 
loss of Smg1 actually causes a strong stabilization of the GFP::SV40 3’ UTR reporter 
(Metzstein and Krasnow, 2006), which has a viral 3’ UTR that contains an intron, 
suggesting Smg1-dependent NMD may contribute more to the degradation of targets 
with these features. The incomplete loss of NMD activity in Smg6 mutants also indicates 
that Smg6-indepdendent decay is sufficient to maintain most NMD activity. However, 
the weak defect of Smg6 mutants does not necessarily mean that most NMD activity 
occurs through the Smg6-independent pathway. It is possible that under wild-type 
conditions, most NMD occurs via Smg6 endonuclease activity, and that Smg6-
independent decay contributes very little to NMD, but only during loss of Smg6 does this 
alternative decay pathway perform the bulk of NMD activity. It is also possible that the 
preference for which decay mechanism degrades NMD targets may be different between 
individual NMD targets, or in tissue- or developmental-specific contexts. It will be 
important to identify the Smg6-independent decay mechanism to parse the relative 
contribution of each decay pathway to the degradation of NMD targets to understand the 
potential mechanism of the bias in decay. 
 
Summary 
 Here we performed the first double mutant analysis of multiple NMD factors, 
providing genetic analysis of the relative contribution of individual NMD genes. We also 
characterized the first Drosophila Smg5 mutants, identifying that Smg5 is critical for 
NMD function and viability, similar to Upf1 and Upf2. This is the first genetic analysis 
of Smg5 function in a model system where Smg5 is required for viability. Our findings 
suggest that NMD utilizes multiple branched decay mechanisms to destroy its targets. 
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All of these pathways depend on Smg5. Our study indicates the importance of Smg5 has 
been underappreciated. More closely characterizing the molecular mechanisms of Smg5 




Figure 3.1. Screens for novel NMD defective mutations identify Smg5 mutants. (A) 
Scheme to detect heterozygous novel mutations in genes required for NMD. The GAL4 
transcription factor ubiquitously expressed by the da promoter activates transcription at 
the UAS promoter, expressing FLP recombinase and the NMD sensitive eGFP::sv40 3’ 
UTR fluorescent reporter. This reporter mRNA is degraded by NMD, and thus has 
increased fluorescence in cells lacking NMD activity. FLP recombinase recombines 
chromosomes at FRT sites (white box). When FLP-mediated recombination occurs 
during G2 phase, the arms of sister chromatids can be exchanged, and homozygous 
chromosome arms can be inherited by daughter cells. If recombined chromosome arms 
contain a mutation in an NMD factor, then the daughter cell and all subsequent lineage 
will have increased GFP fluorescence compared to homozygous wild-type sisters and 
unrecombined cells. (B) Example of mosaic GFP reporter fluorescence phenotype. Late 
L3 larvae expressing the NMD sensitive eGFP::sv40 3’ UTR fluorescent reporter in 
animals with the FRT40A site that are either homozygous wild-type (left) or heterozygous 
for a mutation in Smg5 (right). Clones with increased GFP fluorescence are indicated by 


























Figure 3.2. Smg5 is required for viability and all NMD activity in Drosophila. (A) 
Adult viability of Smg5 mutant alleles trans-heterozygous with either a deficiency 
removing the Smg5 locus (Df) or with two Smg5 mutant alleles. Error represents 95% 
confidence interval of the binomial distribution. * indicates p < 0.05 compared to + / Df 
condition determined by the test of equal or given proportions. (B) Diagram of isolated 
Smg5 mutations. Four alleles (A1, EI1, MI1, and G115) are nonsense mutations. C391 is 
a mutation in a splice acceptor site. Q454 and Q376 are missense mutations. Red 
represents loss-of-function alleles; blue represents hypomorphic alleles. Amino acid 
change is listed under allele names. (C) Expression of the endogenous NMD target 
Gadd45, as measure by qRT-PCR. Error bars represent 2 SEM. (D) Relative abundance 
of PTC-containing dHR783 (Fisk and Thummel, 1998) allele mRNA compared to wild-
type dHR78 allele mRNA abundance in animals heterozygous for dHR783 in each 
indicated genotype. Error represents 2 SEM. * indicates p < 0.05 compared to + / 
Smg5G115 condition determined by two-sided Student’s t-test. (E) Adult viability of 
Smg5C391/G115 and Smg5C391/G115 Gadd45F17 mutants. Loss of Gadd45 suppresses Smg5 
mutant lethality. Error represents 95% confidence interval of the binomial distribution. * 
indicates p < 10-16 compared to Smg5C391/G115 condition determined by the test of equal 






















































































































































































Figure 3.3. Smg5 is required for endonucleolytic cleavage, but not decapping, of the 
endogenous NMD target Gadd45. (A) Diagram of Gadd45 transcript and 5’ and 3’ q-
PCR primer pairs. Open boxes indicate UTRs; grey boxes indicate coding regions. 5’ 
primer pair is located 5’ to the translation stop site and 3’ primer pair is 3’ to the stop 
site. (B) Gadd45 3’ primer pair expression relative to 5’ primer pair expression in 
indicated genotypes. The 3’ region is preferentially stabilized in pcm14 mutants, but this 
preferential stabilization is lost when either Smg6 or Smg5 are lost. Error bars represent 2 
SEM. * indicates p < 0.05 compared to control condition determined by two-sided 
Student’s t-test. (C) Expression of the endogenous NMD target Gadd45 measured by q-
PCR using the 5’ primer pair in indicated genotypes, normalized to the expression in the 
control condition. Error bars represent 2 SEM. * indicates p < 0.05 compared to control 
condition determined by two-sided Student’s t-test. (D) Relative expression of Gadd45 
in pcm14 mutants compared to pcm+ animals in either a control or Smg5C391/G115 























































































































































Figure 3.4. Smg1 NMD function is completely dependent on Smg6 activity. (A) 
Adult viability of Smg132AP and Smg6292/Df null mutants, and Smg132AP; Smg6292/Df double 
mutants. Error represents 95% confidence interval of the binomial distribution. * 
indicates p < 0.05 compared to Smg132AP condition determined by the test of equal or 
given proportions. (B) Expression of the endogenous NMD target Gadd45 in Smg132AP 
and Smg6292/Df null mutants, and Smg132AP; Smg6292/Df double mutants. Error represents 2 
SEM. * indicates p < 0.05 compared to control condition determined by two-sided 
Student’s t-test. (C) Percentage of animals that die during larval development, pupal 
development, or adulthood in Smg6292/Df and Smg132AP; Smg6292/Df mutants. Error 
































































































Figure 3.5. Smg1 mutants enhance Smg5 hypomorph, but not null, mutant defects. 
(A) Expression of the endogenous NMD target Gadd45 in Smg132AP and Smg5C391/G115 
null mutants and Smg132AP; Smg5 C391/G115 double mutants, as measure by qRT-PCR. 
Smg132AP increases the expression of Gadd45 in Smg5C391/G115 mutants. Error bars 
represent 2 SEM. * indicates p < 0.05 compared to control condition determined by two-
sided Student’s t-test. (B) Adult viability of Smg132AP and Smg5C391/G115 null mutants and 
Smg132AP; Smg5C391/G115 double mutants. Error represents 95% confidence interval of the 
binomial distribution. * indicates p < 0.05 compared to Smg132AP condition determined 
by the test of equal or given proportions. (C) Expression of the endogenous NMD target 
Gadd45 in Smg132AP and Smg5Q454/G115 null mutants and Smg132AP; Smg5 Q454/G115 double 
mutants, as measure by qRT-PCR. Error bars represent 2 SEM. * indicates p < 0.05 
compared to control condition determined by two-sided Student’s t-test. (D) Adult 
viability of Smg132AP null mutants, Smg5Q454/G115 hypomorphs, and Smg132AP; 
Smg5Q454/G115 double mutants. Error represents 95% confidence interval of the binomial 
distribution. * indicates p < 0.05 compared to Smg132AP condition determined by the test 



















































































































































































Figure 3.6. Model of branched NMD pathways. Our findings suggest that there are 
multiple NMD decay mechanisms. We propose that one decay mechanism is Smg6 
endonuclease activity, which requires Smg5 for Smg6 to be activated, and Smg1 can 
enhance, but is not required for, Smg6 function. We propose that Smg5 is also required 
for a Smg6-independent decay activity. The mechanism for this second decay activity is 












Figure S3.1. Smg5 mutant alleles have enhanced fluorescence of NMD sensitive 
GFP reporter in first instar larval trachea. (A-E) NMD sensitive eGFP::sv40 3’UTR 
fluorescent reporter is expressed in larval trachea by the btl-GAL4 driver in control (A) 
and Smg5 mutant animals isolated in the screen based on Forster et al. (2010) (B-E).  ! !
WT G115 C391Q454 Q376
A B C D E
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Figure S3.2. Smg1 mutants do not enhance the developmental delays or stage of 
lethality of Smg5 mutants. (A) Percentage of animals that die during larval 
development, pupal development, or adulthood in indicated genotypes. Error represents 
95% confidence interval of the binomial distribution. (B) Average number of days spent 
during larval stages of animals that entered pupariation in each indicated genotype. Error 
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ARC1 AND ARC2 MRNA POTENTIALLY CONTRIBUTE  
TO NMD MUTANT LETHALITY 
 
Introduction 
 The eukaryotic nonsense-mediated mRNA decay (NMD) pathway is an 
important mechanism to destroy erroneous mRNAs that contain premature termination 
codons (PTCs). The destruction of PTC-containing mRNAs is a cellular quality-control 
mechanism that prevents the accumulation of truncated proteins that would otherwise be 
produced by these mRNAs, which can have detrimental effects in the cell (Celik et al., 
2015). In addition to this quality-control function, NMD also degrades many wild-type 
endogenous mRNAs as a feature of post-transcriptional gene regulation (Peccarelli and 
Kebaara, 2014). These aspects of NMD are conserved throughout eukaryotes (Conti and 
Izaurralde, 2005), and the importance of NMD pathway function is highlighted by the 
requirement of NMD for viability in most complex organisms (Hwang and Maquat, 
2011). Until recently, it has been unclear whether the source of the lethality of cells 
lacking NMD activity is due to loss of the quality-control function or the gene regulatory 
feature of NMD (Hwang and Maquat, 2011). We have recently identified that a major 
factor contributing to the lethality of Drosophila with mutations in core NMD genes is 
the stabilization and ensuing increased expression of a single endogenous NMD target, 
Gadd45 (Nelson et al., 2016). We also found that Gadd45 orthologues contribute to
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lethality in mammalian cells (Nelson et al., 2016). However, eliminating Gadd45 
expression failed to fully restore viability in either whole Drosophila or mammalian cells 
(Nelson et al., 2016), indicating that there are other factors contributing to NMD mutant 
lethality.  
 Upf1 and Upf2 are key NMD genes and are required for NMD activity. These 
genes also act in processes other than NMD, such as staufen-mediated decay and 
translation initiation (Park and Maquat, 2013; Wilkinson, 2005). Defects in these 
functions may contribute to the residual lethality that occurs when Gadd45 expression is 
lost in Upf1 or Upf2 mutants. Smg5 is also an essential NMD factor, and loss of Gadd45 
does not fully restore viability to Smg5 mutants either (described in Chapter 3). Smg5 is 
not known to function in any NMD-independent pathways, but it is possible that an 
undiscovered NMD-independent function contributes to Smg5 mutant lethality. 
However, given that loss of Gadd45 fails to fully restore viability to multiple different 
NMD mutants, it is likely that the residual lethality is due to loss of NMD activity itself, 
and not the individual NMD-independent activity of each of these genes. 
 The unsuppressed lethality in NMD mutants lacking Gadd45 is likely due to 
excess expression of either PTC-containing mRNAs or other endogenous NMD targets. 
It is very likely additional endogenous NMD targets that influence lethality were missed 
by the suppression screen used to identify Gadd45, since this screen only covered two 
thirds of the autosomes and none of the X-chromosome (Nelson et al., 2016). 
Additionally, only two of the three candidate regions identified from that screen 
contained loci related to increased expression of Gadd45, and the reason for suppression 
by the third region, located on the right arm of the second chromosome, was unidentified 
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(Nelson et al., 2016). Twenty-four genes have been characterized as endogenous NMD 
targets that have strongly increased expression in Drosophila NMD mutants, one of 
which is Gadd45 and two are NMD genes themselves (Chapin et al., 2014). It is possible 
that one of these 21 remaining genes is the factor accounting for the residual lethality in 
NMD mutants lacking Gadd45 expression. Five of these genes are located in regions that 
did not suppress the lethality of Upf2 mutants when removed by a deficiency (Chapin et 
al., 2014; Nelson et al., 2016), and the other 16 reside in untested portions of the 
genome. Interestingly, the third suppressing region identified in this suppressor screen 
does not contain any previously characterized endogenous NMD targets, so it is possible 
the genes responsible for the residual lethality may be unidentified endogenous NMD 
targets. Additionally, since Gadd45 is responsible for the majority of the death of NMD 
mutants, elimination of those factors contributing to the residual lethality may have little 
or no effect on the viability of NMD mutant on their own. This possibility means that 
genes that have little or no effect to suppress the lethality of NMD mutants when lost 
might have a stronger effect when eliminated from an NMD mutant lacking Gadd45, so 
such genes must also be considered. 
 Here we describe the characterization of candidate loci that may contribute to the 
lethality of Drosophila NMD mutants located within the third region identified from the 
deficiency suppressor screen we performed previously. We identify two genes, Arc1 and 
Arc2, that are deleted by the deficiencies that suppress lethality in the uncharacterized 
candidate region and have increased expression in NMD mutants. Interestingly, these 
genes are orthologues of a well-characterized mammalian endogenous NMD target, 
activity-regulated cytoskeleton-associated protein (Arc) (Giorgi et al., 2007). While 
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these genes have little effect on NMD mutant viability themselves, they may be 
responsible for the residual lethality in NMD mutants lacking Gadd45. We also found 
these genes have promoter variation that may influence their expression in response to 
NMD activity. These findings will help identify the contribution of other NMD regulated 
genes to the viability of Drosophila lacking NMD function, and will help to determine if 
only endogenous NMD targets contribute to NMD mutant lethality, or if stabilized PTC-




 Drosophila melanogaster stocks were raised on standard cornmeal/dextrose food 
at 25°. The NMD mutant alleles Upf225G and Smg132AP (Frizzell et al., 2012; Metzstein 
and Krasnow, 2006) are on y w FRT19A chromosomes. Upf225G is balanced over FM7i, 
P{ActGFP}JMR3 (Reichhart and Ferrandon, 1998). Arc1esm18 and Arc1esm113 mutant 
alleles and the Arc1esm115 precise excision control line (Mattaliano et al., 2007) were 
provided by Leslie Griffith. The Arc2JON80 mutant and Arc2JON5 precise excision control 
were isolated as described below. y w FRT19A was used as a control chromosome for all 
experiments. 
For viability tests, we mated flies for three days and collected all progeny each 
day for 10 days, starting 10 days after the cross was initiated. The total numbers of F1 
mutant and balancer males were scored, and the ratio of mutant males to balancer males 
was used to determine mutant animal viability. !
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Deficiency suppressor screen 
We screened autosomal deficiencies from the DrosDel collection (Ryder et al., 
2007). Deficiencies on chromosome 2 were balanced over CyO. We mated males from 
each deficiency stock to y w Upf225G FRT19A/FM7i, P{ActGFP}JMR3 females and scored 
all F1 males for the presence or absence of each balancer. For any given deficiency 
tested, the percentage of Deficiency / + males that are Upf225G mutants, less the 
percentage of CyO / + males that are Upf225G mutants was calculated, producing a 
Deficiency Suppression Score (DSS), which represents the effect of an individual 
deficiency on the increase or decrease in Upf225G viability, while controlling for each 
deficiency’s general influence on viability. A DSS greater than 0.1 indicates suppression 
of lethality. Supplemental deficiencies used were from the Exelixis collection (Parks et 
al., 2004). Deficiency mapping to the Drosophila genome was performed using the 5.1 
genome release. !
RNA isolation and quantification 
For qRT-PCR analyses, we collected five to ten adult Drosophila frozen in liquid 
nitrogen. We isolated total RNA using TRIzol reagent (Invitrogen) and phase-lock tubes 
(5-Prime), and the RNeasy mini kit (QIAGEN). We used on-column RNase-free DNase 
treatment (QIAGEN) to reduce genomic contamination. We determined RNA 
concentration by spectrophotometer and normalized concentration for reverse 
transcription. For reverse transcription, we used random decamers and MMLV8 reverse 
transcriptase (Retroscript Kit, Ambion). We performed qRT-PCR analysis using the 
SYBR Green qPCR Supermix (Bio-Rad) and the Bio-Rad iCycler thermocycler. All 
experimental reactions were performed using three technical replicates and a minimum 
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of three biological replicates per condition, and the expression level of all experimental 
assays was normalized to RpL32 mRNA expression. 
 For all qRT-PCR analyses, we also measured samples that had been made 
without reverse transcriptase to ensure that signal was not due to genomic DNA. Primer 
sequences used were RpL32_1 (ATGCTAAGCTGTCGCACAAA), RpL32_2 




eGFP_F(AGGACGACGGCAACTACAAGAC), and eGFP_R 
(AAGTCGATGCCCTTCAGCTC). 
 
Arc1 3’ UTR and promoter cloning 
 We cloned the UAS-eGFP::Arc1 3’ UTR construct using the primers 
Arc1_3’UTR_XbaI_F (GAAGTCTAGACACGAGGAGTAGGCGAC) and 
Arc1_3’UTR_StuI_R (GAAGAGGCCTACGCAGTTTTCCGTTTCTG) to amplify the 
entire Arc1 3’ UTR from genomic DNA. We cloned the Arc1 promoter::eGFP::Act5C 
3’UTR construct using the primers Arc1_prom_SbfI_F 
(GAAGCCTGCAGGTTGGAGAGCACAGTTTGTGG) and Arc1_prom_XhoI_R 
(GAAGCTCGAGTTTCGCTGCTGTGTGAG) to amplify the Arc1 promoter from 
genomic DNA. PCR fragments were inserted into the Zero Blunt® TOPO® vector 
(Invitrogen), sequenced to assure fidelity, and digested and cloned into a pUAST-attB 
eGFP::Actin5c 3’UTR vector using standard cloning procedures with SbfI and XhoI 
restriction sites to replace the UAS sequence or XbaI and StuI restriction sites to replace 
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the Actin5c 3’UTR. Plasmids were injected by Genetic Services Inc. (Cambridge, MA) 
into a stock containing the VK00027 attP site (Venken et al., 2006) for phiC31 directed 
integration. We used previously described UAS::eGFP::Actin5C 3’UTR animals 
(Metzstein and Krasnow, 2006; Nelson et al., 2016). Constructs were expressed by the 
e22c-GAL4 or da-GAL4 drivers. 
 
Generation of Arc2 mutant alleles 
We produced P-element excision lines from the P{EPgy2}Arc2EY21260 P-element 
insertion line crossed to a Δ2-3 transposase stock. We mated F1 males containing the P-
element and transposase on a CyO balancer to w; Tft / CyO females. Cy+ Tft white-eyed 
F2 males were then individually mated to w; Tft / CyO females. We then collected Tft+, 
Cy males and females to create an isogenic stock from each individually mated F2 male. 
To identify precise excisions, we used the primers Arc2_Test_F 
(TTATTTAAAATCTGCCCAATAA) and Arc2_Test_R 
(CCCATCCACCCCATAAAATA) flanking the P-element insert site to amplify a region 
across the excised P-element. Any detected deletions were subsequently sequenced using 
these same primers. 
 
Arc1 promoter variant determination 
 We tested for Arc1 promoter variants by using two PCR tests. The first tests used 
the primer pair Arc1_prom_SbfI_F and Arc1_prom_XhoI_R, which flank the variant 
region. In the Arc3 variant, these primers amplify a 1594 bp fragment and in the Narc 
variant, these primers amplify a 989 bp fragment. The second test used the Narc_F 
(AGCAGTTTGAAAGCCGGTAA) and Narc_R (CGCATGCAAGCCTCTACA) primer 
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pair, which are located within the unique Narc sequence. This primer pair will not 
amplify a fragment in the Arc3 variant, but it will amplify a 161 bp fragment if the Narc 
sequence is present.  
 To determine which variant is present in the reference sequence for Drosophila 
species related to D. melanogaster, we used the unique Arc3 or Narc sequences in a 
BLAST search to each species genome using the NCBI blastn tool. Whichever search 
had a higher match to the region between Arc1 and Arc2 for each species was 
determined to be the variant in that genome. 
 
Results 
 We previously used a series of deficiencies to identify regions of the genome that 
when deleted suppress the incomplete lethality of the Upf225G hypomorphic mutant 
(Nelson et al., 2016). Two of the three regions identified suppressed Upf225G lethality 
due to reduced expression of genes involved in the Gadd45/Mekk1 stress response 
pathway (Nelson et al., 2016). However, the third region, located from 14,360,425 to 
14,363,886 on the right arm of the second chromosome (Figure 4.1A), does not contain 
any loci known to interact with this pathway. Only one gene, Arc2, entirely resides 
within this region, which is deleted by deficiencies that suppress Upf225G lethality, but is 
not deleted by any deficiencies that fail to suppress lethality (Figure 4.1B). A second 
gene, Tfb1, is partially located within this region, but it is also partially removed by a 
deficiency that does not suppress Upf225G lethality (Figure 4.1B), so it is not considered 
a candidate. 
Arc2 has not been previously characterized as an endogenous NMD target; 
however, it does have a very strong increase in expression in Upf225G mutants (Figure 
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4.1C), indicating it may be a direct or secondary NMD target. Interestingly, the gene 
Arc1, which is paralogous to Arc2 and resides directly next to it (Figure 4.1B), also has 
increased expression in Upf225G mutants (Figure 4.1C). All deficiencies that delete Arc2 
and suppress Upf225G lethality also delete Arc1; however, a deficiency that deletes Arc1 
but not Arc2 does not suppress lethality (Figure 4.1B). Additionally, these deficiencies 
that suppress Upf225G mutant lethality and delete Arc1 and Arc2 strongly reduce both 
Arc1 and Arc2 expression, in either a wild-type or Upf225G mutant background (Figure 
4.1C). It may be possible that suppression occurs due to the combined reduced 
expression of both of these genes, and not necessarily the reduction of one or the other. 
Given that Arc1 and Arc2 are closely related and may have similar function, it is also 
possible that the suppression occurs due to an overall reduced expression of Arc genes, 
independent of whether Arc1, Arc2, or a combination of the two has reduced expression. 
This possibility means that while loss of a single copy of Arc1 through a heterozygous 
deficiency may not be sufficient to suppress Upf225G mutant lethality, complete 
elimination of Arc1 expression may be just as effective at suppressing lethality as the 
reduced expression of Arc1 and Arc2 produced by these deficiencies. 
The mammalian orthologue of Arc1 and Arc2, Arc, is a well-characterized NMD 
target (Giorgi et al., 2007), suggesting these genes may be targeted by NMD in 
Drosophila. Interestingly, the Arc1 3’ UTR is longer than the average Drosophila 3’ 
UTR, a feature common to many Drosophila endogenous NMD targets (Chapin et al., 
2014). To directly test if Arc1 mRNA is targeted by NMD, we attached the Arc1 3’ UTR 
to an eGFP reporter expressed in epidermal cells under GAL4-UAS control using the 
e22c-GAL4 driver. If the Arc1 3’ UTR is targeted by NMD, this construct will have 
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enhanced GFP expression in NMD mutants compared to control animals (Metzstein and 
Krasnow, 2006; Nelson et al., 2016). We found that eGFP::Arc1 3’UTR mRNA 
expression has a two-fold increase in Upf225G mutants compared to control animals 
(Figure 4.1D). Expression of the same eGFP reporter with a 3’ UTR that is not targeted 
by NMD, the Act5c 3’ UTR (Metzstein and Krasnow, 2006), does not have increased 
expression in Upf225G mutations (Figure 4.1D). These results suggest that the Arc1 
3’UTR is sufficient to induce sensitivity to NMD, indicating Arc1 mRNA may be 
directly targeted by NMD. We also wanted to test if NMD influences transcription at the 
Arc1 promoter site as an alternative explanation for the large increase in Arc1 expression 
in NMD mutants. We cloned the region 991 base pairs upstream of the Arc1 open 
reading frame start site (including both promoter and 5’ UTR) as the Arc1 promoter. 
This region was attached to an eGFP reporter with the Act5c 3’ UTR, so that mRNA 
stability would not be affected by NMD. If Arc1 transcription is repressed by NMD 
activity, then this reporter should have increased eGFP expression in an NMD mutant 
compared to a control animal. We found that this reporter may have very slightly 
increased eGFP mRNA expression in mutants lacking the NMD factor Smg1 compared 
to controls (Figure 4.1E), suggesting that Arc1 transcription may also be influenced by 
NMD activity. The weak increase in reporter expression may partially be due to Smg1 
being the NMD factor eliminated in this test, since Smg1 mutants have only a weak 
increase in the expression of endogenous NMD targets (Chen et al., 2005; Metzstein and 
Krasnow, 2006). However, the increase in eGFP expression was much smaller than the 
increase of endogenous Arc1 in these mutants, indicating that this promoter region 
contributes a small amount to the Arc1 mRNA increase in NMD mutants. Importantly, 
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these experiments have only been performed with a single biological replicate, and thus 
are extremely preliminary and should be repeated to substantiate these conclusions. 
To determine if Arc1 or Arc2 contribute to the death of NMD mutants, we tested 
if Arc1 and Arc2 mutants suppress the lethality of Upf225G mutants. We tested 
heterozygous Arc1 mutants (Mattaliano et al., 2007) for suppression of Upf225G mutant 
lethality, and found that they, like the deficiency that only removed one copy of Arc1 
without reducing Arc2 expression, did not increase viability compared to controls 
(Figure 4.2A). We did find that trans-heterozygous Arc1esm18/ems113 mutants partially 
suppressed Upf225G mutant lethality, increasing viability by ~10% (Figure 4.2A). Arc2 
mutants have not been previously described in the literature, so we isolated a novel 
mutation of Arc2 by imprecise excision of the P{EPgy2}Arc2EY21260 P-element, which is 
inserted at the 3’ end of the Arc2 coding sequence (Figure 4.2B). This allele, called 
JON80, is a deletion of 1049 base pairs, removing most of the Arc2 coding region and 
some of the Arc2 promoter without affecting any nearby genes (Figure 4.2B). Arc2JON80 
is lethal as a homozygote, so we could only test heterozygous Arc2 mutants; however, 
Arc2 is not an essential gene, as Arc2JON80 over a deficiency that deletes Arc2 is viable 
(data not shown). We did not test the suppressing effect of Arc2JON80 mutants over a 
deficiency due to the deficiencies removing Arc2 already suppressing Upf225G mutant 
lethality for reasons that may be independent of Arc2. Interestingly, we found that 
heterozygous Arc2JON80 mutants very weakly increase the viability of Upf225G mutants by 
~5% compared to the precise excision control, Arc2JON5 (Figure 4.2C), suggesting that 
Arc2 may also partially contribute to the death of these animals. Together these results 
indicate overall Arc expression, independent of whether it is Arc1 or Arc2, has a minor 
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impact on the viability of Upf225G mutants. Additionally, it appears that increased Arc2 
expression may have a more significant impact than Arc1, because heterozygous Arc2 
mutants can increase Upf225G mutant viability, while only loss of both copies of Arc1 
could increase viability. 
Since the deficiencies that uncover Arc1 and Arc2 are the only deficiencies in a 
candidate region identified from our suppressor screen that do not remove a known 
Gadd45 pathway gene (Nelson et al., 2016), we wanted to test if Arc1 or Arc2 potentially 
act downstream of Gadd45. We measured Arc1 and Arc2 mRNA expression in Upf225G 
mutants and Upf225G; Gadd45F17 double mutants. We found that loss of Gadd45 partially 
reduces the expression of Arc1, but not Arc2, in a Upf225G mutant (Figure 4.2D). This 
finding suggests that Arc1 expression is regulated by activity of the Gadd45 stress 
response pathway; however, Arc2 expression is not influenced by Gadd45. This 
difference in the response of Arc1 and Arc2 expression to Gadd45 activity is surprising 
given that Arc1 and Arc2 share the same region of the genome as a promoter, although in 
different orientations. 
The Arc1/Arc2 promoter region itself is a particularly interesting feature. In the 
reference genome, Arc1 and Arc2 are oriented in opposite directions, with a region of 
1627 base pairs in between them. This region serves as the promoter for both of these 
genes. The pseudogene Arc3, a duplication of most of the Arc1 3’ UTR that is not 
expressed, also resides in this region (Mattaliano et al., 2007), and presumably 
contributes to the regulation of the transcription of these two genes. Interestingly, when 
cloning the Arc1 promoter, we discovered that many Drosophila lines have a completely 
different region between Arc1 and Arc2. This previously uncharacterized region is 
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shorter than the reference sequence, and completely lacks the Arc3 pseudogene, instead 
replacing it with an entirely different sequence that is shorter than Arc3 and unrelated to 
any other region of the genome (Figure 4.3A). We termed this novel region “not Arc,” 
or “Narc.” At first we thought perhaps the inclusion of Arc3 in this region was a 
potential error in the assembly of the Drosophila reference genome; however, when we 
tested this region from the Drosophila line used to assemble the reference genome, we 
found that it contained Arc3 and not Narc (Figure 4.3B). This difference between the 
presence of Arc3 or Narc in the region in between Arc1 and Arc2 suggests that there may 
be variation in the Drosophila melanogaster population of which promoter sequence is 
used. We found that among multiple laboratory and wild Drosophila melanogaster 
strains tested, the Narc sequence was the only variant identified (Figure 4.3C). The 
Upf225G mutant also has the Narc variant, so when cloning the Arc1 promoter, we used 
the Narc sequence instead of Arc3. To test if Arc3 is unique to Drosophila melanogaster, 
we looked at presence of Narc or Arc3 in the promoter of Arc1 in related Drosophila 
species. We found Narc in the reference genome for those species most closely related to 
Drosophila melanogaster, while Arc3 is found in those species more divergent from 
Drosophila melanogaster (Figure 4.3D). This finding suggests that Arc3 may be an 
ancestral variant of the Arc1 promoter, but that there is variation in which sequence is 
used in Drosophila melanogaster and other closely related species. 
 
Discussion 
 The regulation of gene expression is an important feature to maintain cellular 
homeostasis. The nonsense-mediated mRNA decay (NMD) pathway is one of many 
post-transcriptional gene regulation mechanisms that destroy mRNAs in order to reduce 
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or eliminate their expression (Adjibade and Mazroui, 2014). NMD degrades erroneous 
mRNAs that contain premature termination codons (PTCs), as well as many endogenous 
mRNAs (Kurosaki and Maquat, 2016). Since NMD is required for viability in most 
complex organisms, it has long been unclear if the requirement for NMD activity is due 
to a necessity to degrade PTC containing mRNAs or to regulate the expression of those 
endogenous NMD targets (Hwang and Maquat, 2011). Recently, we identified that 
Drosophila and mammalian cells lacking NMD activity can have their viability partially 
restored when eliminating a single endogenous NMD target, Gadd45 (Nelson et al., 
2016). However, it has remained unclear if the expression of other endogenous NMD 
targets accounts for the remaining lethality in these conditions, or if PTC-containing 
mRNAs are responsible for this death. Here we described how the genes Arc1 and Arc2, 
which were identified in the same screen that identified Gadd45 as a suppressor of NMD 
mutant lethality, are potential factors that may contribute to NMD mutant lethality in 
Drosophila. 
 The deficiency suppressor screen that identified Gadd45 pathway genes as 
suppressors of NMD mutant lethality had one candidate suppressing region that did not 
contain any known Gadd45-related genes (Nelson et al., 2016). Interestingly, this region 
only contained one gene, Arc2. Arc2, and the nearby paralogue Arc1, which is also 
deleted by the same deficiencies that suppress NMD mutant lethality, had increased 
expression in NMD mutants. Although loss of a single copy of Arc1 alone, either by a 
deficiency or mutation, is not sufficient to suppress NMD mutant lethality, loss of both 
copies of Arc1, or heterozygous Arc2 mutants, slightly increased viability. The slight 
suppression in each of these conditions could be due to individual activity of Arc1 or 
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Arc2, or it is possible that combined Arc gene expression contributes to the death of 
NMD mutants. The combined loss of Arc1 and Arc2 may have a stronger effect on 
viability than loss of each individual gene alone, and Arc1 Arc2 double mutants should 
be tested for more complete suppression of NMD mutant lethality. 
 While Arc1 and Arc2 have not been characterized as endogenous NMD targets in 
Drosophila, their mammalian orthologue, Arc, is a well-described endogenous NMD 
target (Giorgi et al., 2007). Arc is located in the dendritic segments of neurons and 
functions in activity-dependent synaptic receptor trafficking (Rodríguez et al., 2005; 
Steward et al., 1998). The regulation of Arc mRNA by NMD is thought to be critical for 
restricting Arc to location and temporally specific activity (Bramham et al., 2008). 
Interestingly, restoration of NMD activity specifically in the nervous system of 
Drosophila Upf2 mutants is able to partially suppress the lethality of these mutants 
(personal communication, A. Chapin), suggesting NMD may have a key function in the 
nervous system during Drosophila development. Given that mammalian Arc functions in 
the nervous system, its possible that misregulation of Arc1 and Arc2 mRNA in the 
nervous system contributes to the lethality of Drosophila NMD mutants. However, Arc1 
has been found to not be necessary for activity-dependent vesicle trafficking in the 
Drosophila neural-muscular junction (Mattaliano et al., 2007), suggesting that the 
function for the Arc genes may not be conserved from Drosophila to mammals. On the 
other hand, Drosophila NMD mutants have reduced synaptic vesicle trafficking (Long et 
al., 2010), which could be the result of excessive Arc1 or Arc2 expression. Given that 
Drosophila express two Arc paralogues while only one is expressed in mammals, it is 
possible that these genes have redundant functions, and both would need to be 
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eliminated to identify a defect in vesicle trafficking in Drosophila. The link between Arc 
neuronal function and the potential key role for NMD in the nervous system during 
development suggests the enticing possibility that over-expression of Arc1 and Arc2 
specifically in the nervous system contributes to NMD mutant lethality. Interestingly, 
over-expression of Arc1 in the nervous system causes a depletion in body fat (Mosher et 
al., 2015), so NMD mutants may also have depleted body fat, which may contribute to 
their failure to develop to adulthood. It should be tested if over-expression of Arc1 and 
Arc2 together in the nervous system can induce lethality, and if RNAi knockdown of 
Arc1 and Arc2 expression in this tissue can suppress NMD mutant lethality to determine 
if Arc gene expression specifically in the nervous system contributes to NMD mutant 
lethality. 
 Arc1 and Arc2 have not been previously identified as endogenous NMD targets 
in Drosophila. Our analysis suggests that both Arc1 transcription and stability may be 
regulated by NMD. The increase in Arc1 transcription in NMD mutants may partially be 
a secondary effect due to increased Gadd45 mRNA stability, because the increased 
expression of Arc1 in Upf225G mutants is reduced when Gadd45 is eliminated. The 
potential for Gadd45 to increase Arc1 transcription in NMD mutants should be further 
examined by testing the expression of the Arc1 promoter::eGFP reporter in NMD 
mutants lacking Gadd45. Arc2 should also be tested for being an endogenous NMD 
target and if transcription of Arc2 is restricted by NMD activity. We found that Gadd45 
expression does not increase Arc2 expression, so if Arc2 is not an endogenous NMD 
target, it will be important to understand how Arc2 transcription increases in NMD 
mutants. 
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  The region between Arc1 and Arc2 is likely the promoter for these two genes. In 
the Drosophila reference strain, this region is approximately 1.5 kb and includes a 
pseudogene, Arc3, which is a repeat of most of the Arc1 sequence and is not expressed. 
We found that almost all Drosophila melanogaster strains we examined do not have the 
Arc3 pseudogene, and this region is instead replaced with an entirely novel sequence that 
is ~600 bp shorter than Arc3. This novel region, which we called Narc, is also found in 
the reference sequence of the four Drosophila species most closely related to D. 
melanogaster, while less related Drosophila species have Arc3 at this location in their 
genome. The variation at the location of the likely Arc1 and Arc2 promoter suggests that 
there could be variation in the expression pattern of these genes between these strains. 
Additionally, the potential influence NMD may have on the transcription of these genes 
could be different depending on which variant promoter is present. It will be important to 
determine the impact on the expression pattern that these variant promoter regions have 
on Arc1 and Arc2 in both an NMD+ and NMD- context. More strains of the other related 
Drosophila species should be tested for this variant to determine if these strains also 
have variation at this region like D. melanogaster, or if these species only have one 
version of the Arc1 and Arc2 promoter. The potential of transcriptional differences 
between these promoters and standing variation of these promoters across multiple 
Drosophila species may reveal an interesting evolutionary phenomenon. It is possible 
that the degradation of Arc1 and Arc2 mRNA by NMD is a more important regulator of 
their expression than transcription, allowing for variant promoters to exist. 
 Here we uncovered two potential endogenous NMD targets, Arc1 and Arc2, that 
may be contributing to lethality in NMD mutants. The increased expression of these 
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genes is partially dependent on Gadd45 expression, but most of their expression appears 
to be independent of this pathway. It is possible then that Arc1 and Arc2 may be 
responsible for the residual lethality that occurs in NMD mutants lacking Gadd45, as 
opposed to being entirely dependent on Gadd45 activity. These mutants should be tested 
for their capacity to increase the viability of NMD mutants lacking Gadd45 expression. 
The potential for Arc1 and Arc2 to be critical NMD targets needs to be further 
investigated and validated, but they currently are promising candidates. 
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Figure 4.1. Arc1 and Arc2 candidate NMD targets that mediate NMD mutant 
lethality. (A) The region from 14,360,425 to 14,363,886 on the right arm of the second 
chromosome is removed by deficiencies that suppress Upf225G lethality (Green) but not 
any deficiencies that fail to suppress Upf225G mutant lethality (White) from Nelson et al., 
2016. Black boxes on chromosome above deficiencies indicate gene locations. (B) 
Smaller scale representation of the 3.4 kb candidate suppressing region. White boxes 
indicate untranslated regions; gray boxes represent coding region; line between boxes 
represents introns; arrow head indicates direction of transcription. (C) Arc1 and Arc2 
mRNA expression, measured by qRT-PCR, in indicated genotypes. Df(2R)ED2354 is a 
deficiency that deletes Arc1 and Arc2 and suppresses Upf225G mutant lethality. 
Df(2R)2423 is a control deficiency that does not delete Arc1 or Arc2 and does not 
suppress Upf225G mutant lethality, but has an identical background to Df(2R)ED2354. 
All mRNA expression is normalized to expression in the Df(2R)ED2423 condition. Error 
bars represent 1 SD. Upf225G; Df(2R)ED2423 and Upf225G; Df(2R)ED2354 conditions do 
not have error bars because they represent a single replicate. (D) Relative GFP mRNA 
expression in control and Upf225G mutant animals expressing the GFP coding sequence 
with either the Arc1 3’UTR or the Act5c 3’UTR via e22c-GAL4. Expression is 
normalized to the control condition. There are no error bars because each condition 
represents a single replicate. (E) Relative GFP and Arc1 mRNA expression in animals 
expressing GFP::Act4c 3’UTR from the Arc1 promoter in control or Smg132AP mutant 
background. Expression for each mRNA is normalized to the control condition. There 































































































































Figure 4.2. Arc1 and Arc2 potentially contribute to NMD mutant lethality. (A) 
Percentage of expected animals that survive to adulthood in Upf225G mutant animals in 
the indicated backgrounds. esm115 is a control allele; esm18 and esm113 are Arc1 
mutant alleles (Mattaliano et al., 2007). Error bars represent the 95% confidence interval 
of the binomial distribution. * indicates p < 0.05 between condition and control 
determined by the test of equal or given proportions. (B) Schematic of the Arc2JON80 
imprecise P-element excision mutant allele. JON80 is an imprecise excision of the 
P{EPgy2}Arc2EY21260 P-element that deletes 1049 bp, removing most of the Arc2 coding 
sequence. JON5 is a precise excision of this P-element. Coding region in gray; 
untranslated regions in white. (C) Percentage of expected animals that survive to 
adulthood in Upf225G mutant animals in Arc2JON5/+ or Arc2JON80/+ backgrounds. Error 
bars represent the 95% confidence interval of the binomial distribution. * indicates p < 
0.05 between condition and control determined by the test of equal or given proportions. 
(D) Arc1 and Arc2 mRNA expression, measured by qRT-PCR, in Upf225G mutants and 
controls with and without Gadd45. All expression is normalized to the control condition. 
Error bars represent 1 SD. * indicates p < 0.05 between condition and control determined 




































































































































Figure 4.3. Arc1 and Arc2 have a variable promoter. (A) Schematic of the two 
variants for the region between Arc1 and Arc2. Arc3 (red box) is a 1,347 bp region and 
Narc (blue) is 733 bp long. Arrow heads indicate primer pairs used to genotype region 
for Arc3 or Narc. The Narc primers are specific to the unique Narc sequence. (B) 
Drosophila melanogaster lab strains contain the Narc sequence and the reference 
sequence strain contains Arc3 when genotyped with flanking primer pair or Narc 
specific primers. (C) Narc genotyping in wild and lab D. melanogaster strains. All 
strains tested contain the Narc sequence. (D) Variant presence in Drosophila species 
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 Nonsense-mediated mRNA decay (NMD) is a critical mRNA degradation 
pathway that serves dual functions as a cellular quality-control mechanism and a feature 
of post-transcriptional gene regulation. NMD degrades both erroneous mRNAs that 
contain premature termination codons -- preventing the expression of potentially harmful 
truncated proteins (Celik et al., 2015) -- and error-free endogenous mRNAs, thereby 
silencing their expression (Peccarelli and Kebaara, 2014). While the quality-control 
feature has generally been focused on as the primary NMD function, NMD influences 
the expression of approximately 10% of the genome in many species, indicating that it 
has a significant impact on gene expression (Barberan-Soler et al., 2009; Chapin et al., 
2014; Hansen et al., 2009; He et al., 2003; Lewis et al., 2003; Nguyen et al., 2014; 
Ramani et al., 2009; Rehwinkel, 2005; Tani et al., 2012). Importantly, NMD is required 
for viability in most complex organisms (Frizzell et al., 2012; Kerényi et al., 2008; Li et 
al., 2015; McIlwain et al., 2010; Medghalchi et al., 2001; Metzstein and Krasnow, 2006; 
Thoren et al., 2010; Weischenfeldt et al., 2008; Wittkopp et al., 2009), highlighting the 
key contributions of this pathway for development and cellular homeostasis. The dual 
roles of NMD activity and the requirement of this pathway for viability raise two 
important questions: 1) Why is NMD required for viability? and 2) How does NMD 
recognize and degrade these two types of targets? The work described in this dissertation 
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will contribute to understanding these key questions about the NMD pathway. 
Specifically, this dissertation identifies the relative contribution of the separate NMD 
functions to the lethality of animals and cells lacking NMD activity, and reveals 
branched NMD mechanisms for target degradation. These findings uncover new aspects 
of NMD activity and raise several questions about the role of the NMD pathway in RNA 
metabolism that prompt future experiments that will be discussed throughout this 
chapter. 
 
NMD-Mediated Gene Regulation Is Critical for Viability 
 Chapter 2 of this dissertation addressed understanding the source of lethality in 
animals and cells lacking NMD activity. We approached this question with the 
hypothesis that the cause of lethality when NMD is lost is the increased expression, and 
thus over-activity, of specific endogenous NMD targets that can reduce cell viability. To 
test our hypothesis, we sought to suppress the incomplete lethality of a Drosophila 
hypomorphic allele of the core NMD factor Upf2 (Metzstein and Krasnow, 2006) 
through elimination or reduced expression of individual genes. We identified three 
regions of the genome that suppressed the lethality of these mutants when deleted, 
revealing approximately 80 candidate genes that contribute to NMD mutant lethality. 
One of these genes, Gadd45, is an endogenous NMD target that has increased expression 
in NMD mutants (Chapin et al., 2014). We also identified that Mekk1, an orthologue of 
mammalian MTK1/MEKK4 (Inoue et al., 2001), which is activated by Gadd45 protein 
in a concentration-dependent manner (Takekawa and Saito, 1998), was located within 
another suppressing region. We found that elimination of either Gadd45 or Mekk1 alone 
was sufficient to restore viability to animals completely lacking NMD activity, revealing 
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that increased expression of Gadd45 is a major factor contributing to NMD mutant 
lethality. We then established that excessive Gadd45 is responsible for the ectopic cell 
death in the developing wing disc of NMD mutant larvae, and that mammalian 
orthologues of Gadd45 also contribute to the death of mammalian cells lacking NMD 
function. 
 The findings described in Chapter 2 have many important implications for 
understanding NMD function and potentially developing therapies to treat genetic 
disease. Since NMD was first discovered to be required for viability, it has been unclear 
if cells lacking NMD activity die due to loss of the gene regulatory function or the 
quality control function (Hwang and Maquat, 2011). Our findings indicate that the gene 
regulatory feature is the key aspect of NMD activity that is essential for viability. NMD 
mutants lacking the single endogenous target Gadd45 have restored viability, indicating 
that the surveillance feature of the NMD pathway is not required for these animals to 
survive. We also confirmed that PTC-containing mRNAs are fully stabilized in viable 
NMD mutants lacking Gadd45 expression, indicating that expression of PTC-containing 
mRNAs per se do not induce cell death. However, some NMD mutants lacking Gadd45 
still die, which may be due to an accumulation of many different or a specific subset of 
PTC-containing mRNAs in these animals. PTC-containing mRNAs are spontaneously 
created due to errors that occur in transcription and splicing at a low, but appreciable, 
rate of around 10-4 (Rosenberger and Foskett, 1981; Shaw et al., 2002), meaning random 
truncated polypeptides are likely being translated in NMD mutant cells. The cumulative 
expression of multiple truncated proteins, or perhaps the unfortunate production of a 
single particularly harmful truncated protein, may reduce cellular viability in these 
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animals. The NMD mutants lacking Gadd45 may be a useful tool to identify those PTC-
containing mRNAs that are tolerable, and the combination or individual PTCs that can 
induce lethality. Upf2; Gadd45 double mutants could be crossed to a series of 
Drosophila lines containing recessive nonsense mutations, and test which mutations, 
singly or in combination, induce heterozygous lethality specifically in an NMD mutant 
background. Characterizing those alleles that are recessive in an animal with functioning 
NMD but cause dominant lethality in animals lacking NMD will help to understand the 
detrimental nature of truncated polypeptides. This understanding may potentially be used 
to develop a method to use sequence alone to predict if a particular nonsense mutation is 
possibly harmful or benign in the absence of NMD activity. 
 It is important to identify what PTC-containing mRNAs may be tolerable if 
stabilized because suppression of NMD is considered a potential therapy for a wide 
range of recessive genetic diseases (Miller and Pearce, 2014). Recessive loss of function 
diseases are often the result of both copies of a gene having nonsense mutations, so all 
mRNA transcribed from those loci are degraded by NMD, causing loss of all gene 
function. In some cases, such as mutations in DMD and CFTR, PTC-containing alleles 
that are not degraded by NMD cause less severe symptoms than those alleles that are 
degraded by NMD (Kerr et al., 2001; Rowntree and Harris, 2003). Inhibiting NMD in 
cases where expression of a PTC-containing mRNA may be better than loss of gene 
function would provide a general therapy for many loss of function diseases, including 
rare diseases that my not otherwise have therapies established. The lethality of loss of 
NMD function has blocked development of this potential therapy, but the identification 
that Gadd45 as a critical factor causing this lethality suggests that co-inhibition of 
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Gadd45 with NMD may be a viable treatment. Gadd45 inhibitors already exist 
(Tornatore et al., 2014), so progress for this potential therapy could be rather quick, and 
it should be immediately tested. Given that approximately a third of genetic diseases are 
due to loss-of-function mutations (Khajavi et al., 2006), a general therapy for treating 
many of these diseases would have a wide impact on medicine. 
 The discovery that degradation of Gadd45 mRNA by NMD is required for 
viability raises an important new question: why would this mechanism to regulate 
Gadd45 expression have evolved? There are two likely possibilities that may explain the 
benefit of this post-transcriptional regulation of a gene that can induce cell death. The 
first explanation is that this mechanism may limit the amount of protein produced by 
each Gadd45 mRNA molecule. NMD is translation-dependent (Popp and Maquat, 2014), 
so Gadd45 mRNAs would translate at least one molecule of Gadd45 protein before 
being degraded by NMD. Gadd45 is transcribed in response to septic injury in 
Drosophila (Peretz et al., 2007) or a variety of cell stresses in mammalian cells 
(Papathanasiou et al., 1991; Takekawa and Saito, 1998), initiating a signaling cascade 
that promotes cell death (Harkin et al., 1999). It is possible that quick degradation of 
Gadd45 mRNAs is essential after their translation to ensure an acute response to these 
stressors, creating a burst of protein synthesis with the burst of transcription. Prolonged 
translation of Gadd45 may produce a chronic response that would be harmful to the cell. 
A similar explanation is proposed for the degradation of Arc mRNA by NMD in the 
mammalian nervous system (Bramham et al., 2008). The second possible explanation for 
why NMD would degrade Gadd45 mRNA may be that this gene regulatory mechanism 
would cause a rapid increase in Gadd45 expression if NMD is inhibited. NMD can 
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restrict the replication of some viruses (Balistreri et al., 2014), likely because many viral 
transcripts are polycistronic and thus look like PTC-containing mRNAs, which may be 
degraded by NMD. To combat the potential anti-viral NMD activity, many viruses have 
evolved trans-acting mechanisms to inhibit NMD function (Mocquet et al., 2012). 
Regulation of Gadd45 expression by NMD may serve to act as a “molecular tripwire” 
that senses this viral activity and causes a quick increase in Gadd45 expression upon 
infection to induce cell death and prevent viral replication. Interestingly, NMD degrades 
the mRNAs encoding a subset of immune-related receptors that can promote cell death 
in Arabidopsis, and this regulation also is thought to function as a similar anti-viral 
activity (Gloggnitzer et al., 2014). While the specific NMD targets are not conserved in 
these cases, it is possible that the function of NMD as a molecular sensor to stimulate an 
immune response upon infection is conserved between plants and animals. These two 
potential functions for the repression of Gadd45 expression by NMD are not necessarily 
mutually exclusive, and both would tie NMD function to innate immune activity. The 
potential role of NMD and Gadd45 in the innate immune response of Drosophila should 
be further investigated to test these possibilities and better understand the this regulatory 
mechanism. 
 
Smg5 Is Required for NMD Targets to Be Degraded by  
Multiple Independent Decay Mechanisms 
 Chapter 3 described the first genetic analysis of animals with mutations in 
multiple NMD factors in a model organism where NMD is required for viability. Most 
model organisms that require NMD die when any individual NMD gene is eliminated  
(Frizzell et al., 2012; Kerényi et al., 2008; Li et al., 2015; McIlwain et al., 2010; 
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Medghalchi et al., 2001; Metzstein and Krasnow, 2006; Thoren et al., 2010; 
Weischenfeldt et al., 2008; Wittkopp et al., 2009); however, Drosophila with mutations 
in individual NMD genes have variable effects on viability. Drosophila can survive 
when Upf3, Smg1, or Smg6 function is eliminated (Avery et al., 2011; Chen et al., 2005; 
Frizzell et al., 2012; Metzstein and Krasnow, 2006), but loss of Upf1, Upf2, or, as 
described in Chapter 3, Smg5 activity causes the animals to die before reaching 
adulthood (Frizzell et al., 2012; Metzstein and Krasnow, 2006). This study is the first in-
depth genetic analysis of Smg5 function in any model organism, and identified that Smg5 
is a critical component of the NMD pathway, like Upf1 and Upf2. Importantly, our 
double mutant analysis revealed that the variability in the requirement of individual 
NMD genes for Drosophila viability is due to there being multiple mechanisms for 
NMD target degradation. We identified that in addition to the well-characterized Smg6 
endonuclease, at least one other mechanism exists to degrade NMD targets, and propose 
that Smg5 is required for both of these degradation activities. Additionally, we found that 
all Smg1 decay activity requires Smg6 function, consistent with the models proposed 
from biochemical analysis of Smg1 (Hug et al., 2016). However, we also identified that 
Smg6 likely has Smg1-independent activity, providing an in vivo context for recent 
claims that Smg6 can bind Upf1 without Smg1 kinase activity (Chakrabarti et al., 2014; 
Nicholson et al., 2014). Together, these analyses indicate that, at least in Drosophila, the 
activity of the NMD pathway is much more complex that previously proposed. 
 This analysis is the first time that multiple NMD mechanisms have been 
described in Drosophila, and the first time that Smg5 has been implicated in the 
degradation of NMD targets during native NMD conditions. However, this study is not 
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the first time that multiple NMD mechanisms have been proposed. Co-depletion of Smg6 
and Smg7 in HeLa cells has previously been shown to enhance defects in NMD function 
compared to depletion of Smg6 alone (Loh et al., 2013; Metze et al., 2013), suggesting 
independent decay mechanisms exist. However, this additive defect may have been the 
result of compounding incomplete knockdown of two factors required for the same 
function. By using true complete loss of function conditions via genetic mutations, we 
found that additive defects between Smg1 and Smg5 hypomorphs confirm that there are 
multiple NMD mechanisms. The complete set of NMD double mutants should be tested 
in Drosophila for enhanced defects in NMD activity to dissect the distinct activities of 
each NMD factor and fully understand the multiple decay mechanisms utilized by this 
pathway. 
 Smg5 and the paralogous Smg7 (which is not encoded for in the Drosophila 
genome) have been implicated to potentially recruit both decapping and deadenylation 
machinery to NMD targets to promote exonucleolytic decay, but it is unclear if these 
functions occur during native NMD activity (Cho et al., 2013; Loh et al., 2013). In HeLa 
cells, Smg5 can bind PNRC2, which bridges an interaction with Dcp1a (Cho et al., 2013; 
2009), a member of the DCP decapping complex. Artificial tethering of Smg5 to an 
mRNA can elicit RNA degradation, but depletion of PNRC2 prevents Smg5-tethered 
mRNAs from being degraded (Cho et al., 2013), suggesting Smg5 interacting with 
PNRC2, and thus Dcp1a, is required for Smg5-dependent decay. These findings suggest 
that Smg5 may recruit a decapping complex to NMD targets to initiate 5’-to-3’ 
exonuclease activity in mammalian and potentially Drosophila cells. However, we found 
that the decay activity of the sole cytoplasmic 5’-to-3’ exonuclease Xrn1 (encoded by 
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pcm) is completely independent from Smg5 function in Drosophila, indicating that Smg5 
does not recruit any decapping complex in the fly. This finding does not mean that 
NMD-mediated decapping does not occur in Drosophila, but simply that Smg5 is not 
required for this activity. Upf1 directly recruits a decapping complex in both yeast and 
mammalian cells (Lykke-Andersen, 2002; Tarassov et al., 2008), so it is likely that Upf1 
has similar activity in Drosophila, and the potential overlap between Upf1 and pcm 
function should be tested. As an alternative explanation for Smg5-dependent decay 
activity, it has been shown in HeLa cells that Smg7 can directly interact with POP2, a 
component of the CCR4-NOT deadenylase complex (Loh et al., 2013), potentially 
promoting deadenylation and subsequent 3’-to-5’ exonucleolytic cleavage of NMD 
targets. Smg7 is paralogous to Smg5, and while the Drosophila genome does not encode 
a Smg7 orthologue, Drosophila Smg5 has many conserved regions with human Smg7 
(Chiu et al., 2003; Fukuhara et al., 2005) and may have some of the same interactions. It 
is then possible that Drosophila Smg5 may recruit a deadenylation complex to promote 
NMD target decay. The findings from Chapter 3 suggest that it is likely that Smg5 
recruits a deadenylase complex, given that Smg5 does not contribute to 5’-to-3’ 
exonuclease decay, but is necessary for some endonuclease-independent decay 
mechanism. Double mutants for Smg5 and POP2, or other factors essential for 
deadenylation or the cytoplasmic 3’-to-5’ exonuclease, should be tested for enhanced 
defects in NMD activity to determine if this potential mechanism occurs in vivo in 
Drosophila.  
 The potential for multiple NMD mechanisms described in Chapter 3 opens the 
possibility that there is preference for one mechanism over the other in a target-
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dependent context. Depletion of individual NMD factors has varying impacts on NMD 
targets containing or lacking an exon-junction complex (EJC) depending on which factor 
is removed (Metze et al., 2013), suggesting EJC presence may be a signal to prefer one 
decay mechanism over another. Additionally, analysis in human cells identified that 
Smg6 endonuclease activity is the primary decay mechanism for endogenous NMD 
targets (Lykke-Andersen et al., 2014), but it is unclear if there is difference in this 
preference between individual targets or classes of targets. One decay mechanism may 
preferentially degrade endogenous NMD targets rather than PTC-containing mRNAs, or 
there may be a difference in which mechanism is used based on the length of the 3’ UTR 
of a target. The null mutant for the lone Drosophila cytoplasmic 5’-to-3’ exonuclease 
pcm (Till et al., 1998) may be a useful tool to determine if there is variability in the 
decay mechanism between different endogenous NMD targets. pcm mutants have 
increased stability of the 3’ regions of NMD targets cleaved by Smg6 compared to the 5’ 
regions (Nelson et al., 2016). This bias in the abundance of two parts of a single mRNA 
occurs because Smg6 cleaves the mRNA near the stop codon, and the 5’ fragment is 
degraded by a 3’-to-5’ exonuclease, but the 3’ fragment is not degraded because pcm is 
removed. The difference in abundance between the 3’ region and the 5’ region of 
mRNAs in pcm mutants may serve as a readout for Smg6 endonuclease activity. 
Comparing the stabilization of 3’ fragments in pcm mutants to the total increase in 
expression of a given mRNA during complete loss of NMD function would be able to 
determine the relative contribution of Smg6 endonuclease activity to any given NMD 
target. For example, if the difference in expression of an mRNA between the 3’ region 
and 5’ region in a pcm mutant is equal to the difference in expression between complete 
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loss of NMD activity and a control condition, it suggests that all NMD activity on that 
mRNA occurs through Smg6. Alternatively, a transcript may have no difference in 
expression between the 3’ region and 5’ region in a pcm mutant, but has increased 
expression in NMD mutants, indicating all NMD activity on that mRNA is Smg6-
independent. RNA-sequencing analysis in pcm mutants, NMD mutants, and controls 
would be able to make this comparison across all transcripts, and could determine if 
there is variation in the relative amount of Smg6 activity for any individual NMD 
targeted gene. Identifying the potential variation in preference for the independent NMD 
mechanisms would provide a new foundation for understanding the mechanisms of how 
targets are degraded. 
 
Tissue Specific Regulation of Arc1 and Arc2 by NMD May 
Be Essential for Viability 
 Chapter 4 described how two related genes, Arc1 and Arc2, may also contribute 
to the lethality of NMD mutants. These genes both have increased expression in Upf2 
mutants, and heterozygous deficiencies that simultaneously delete both genes partially 
suppress Upf2 mutant lethality. Arc1 and Arc2 have not been previously characterized as 
endogenous NMD targets; however, we found that the Arc1 3’ UTR may be sensitive to 
NMD. Additionally, we found the increase in expression of Arc1, but not Arc2, in Upf2 
mutants is partially dependent on Gadd45 expression, suggesting Arc1 may function 
downstream of Gadd45 activity. These findings may indicate that Arc1 and Arc2 
contribute to the lethality that occurs in some NMD mutants lacking Gadd45 expression, 
and would further clarify the source of lethality in animals lacking NMD activity. 
 Arc1 and Arc2 are particularly interesting candidates for being endogenous NMD 
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targets that partially mediate the lethality of NMD mutants because the mammalian 
orthologue of these genes, Arc, is a well-characterized endogenous NMD target (Giorgi 
et al., 2007). Arc functions in synaptic vesicle trafficking in neuronal cells (Rodríguez et 
al., 2005; Steward et al., 1998), and restoration of NMD in the Drosophila nervous 
system is sufficient to partially suppress the lethality of NMD mutants (Personal 
Communication, A. Chapin). An enticing possibility is that increased expression of Arc1 
and Arc2 specifically in the nervous system may be a source of lethality in Drosophila 
NMD mutants. However, loss of Arc1 was found to not have an effect on synaptic 
vesicle trafficking in the Drosophila neural-muscular junction (Mattaliano et al., 2007), 
suggesting Arc gene function is not conserved in these species. It is possible that Arc1 
and Arc2 have redundant functions in vesicle trafficking though, and double mutants 
should be tested for defects in this process. Additionally, while reduced expression of 
either Arc1 or Arc2 had a minor increase in NMD mutant viability, elimination of both 
Arc1 and Arc2 might have a stronger effect on suppression of NMD mutant lethality than 
loss of either single gene.  
The potential that increased expression of Arc1 and Arc2 represent tissue-specific 
consequences of loss of NMD is exciting because it would begin to uncover the tissue 
specific functions of this ubiquitous mRNA degradation pathway. It is possible that 
NMD activity may be differently modulated in specific cell types or during certain 
developmental stages, so uncovering those tissues where NMD is required for viability 
will be the first step to understanding the potential modulation of NMD function. 
Interestingly, the response to reduced expression of individual NMD factors varies 
between cell types in mice (Huang et al., 2011), and NMD activity is endogenously 
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reduced specifically in developing mouse neuronal cells via expression of a miRNA that 
targets Upf1 (Bruno et al., 2011). These reports support the idea that differential 
modulation in NMD activity exists, at least between tissues. Arc1 and Arc2 are enticing 
possibilities for being additional contributing factors to NMD mutant lethality in 
Drosophila, and the potential that their over-expression in the nervous system induces 
lethality should be tested. Additionally, neuronal specific reduction in Arc1 and Arc2 
expression should be tested for partial suppression of NMD mutant lethality to test if 
there is a tissue-specific effect on viability in these mutants. 
 
Summary 
 All together, this dissertation describes several advancements to the 
understanding of the mechanisms and biological roles of the nonsense-mediated mRNA 
decay pathway. The discovery that the endogenous NMD target Gadd45 is a major 
factor causing the lethality of both Drosophila and mammalian cells lacking NMD 
answers a long-standing question in the field. This finding will push the field to further 
understand and appreciate the gene regulatory role of the NMD pathway, and opens the 
possibility for NMD inhibition therapies to treat loss-of-function genetic diseases. 
Identifying that there are multiple NMD mechanisms in Drosophila reshapes the model 
of how the NMD process occurs, and may reveal a new understanding of how to define 
different NMD targets. The existing model of NMD function has been formed mostly 
through the characterization of the biochemical interactions that can occur between the 
NMD factors, but these interactions will need to be re-interpreted through the in vivo 
genetic analysis that has been presented in this dissertation. Additionally, uncovering 
that Smg5 is a critical NMD gene required for these branched pathways highlights Smg5 
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as a previously underappreciated NMD factor, which has been of relatively little research 
focus compared to other NMD genes. There should be a shift to emphasize 
understanding the role of Smg5 in the NMD mechanism to better characterize this newly 
revealed crucial factor. These findings will provide the critical foundation for future 
research to better understand the NMD pathway. 
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